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ABSTRACT OF THE DISSERTATION 
 
From Molecules to Genes and Back Again: Tales of Marine Microbes and their Specialized 
Chemistry 
by 
Michelle Antoinette Schorn 
 
Doctor of Philosophy in Marine Biology 
 
University of California, San Diego, 2018 
 
Professor Bradley S. Moore, Chair 
 
 Nature has created elegant and efficient ways of assembling a wide variety of diverse 
chemical scaffolds. Microbes are prolific producers of these secondary metabolites, which can 
have profound bioactivities and be harnessed for use in medicine. Within their genomes, 
microbes possess the blueprints for making natural products, and recent advances in high-
throughput DNA sequencing have revealed a much larger repertoire of specialized chemistry 
than what can be observed in the lab. This bacterial ‘dark matter’ has the potential to contain 
 xvii 
 
the instructions for making countless new chemical scaffolds and represents an untapped 
source for drug discovery. Connecting secondary metabolite compounds with their 
biosynthetic gene clusters can inform novel biosynthetic transformations, provide a renewable 
source of promising bioactive compounds, and inspire synthetic biology approaches to 
assembling new molecules. Chapter 2 of this dissertation connects two pharmaceutically 
relevant natural products with their corresponding biosynthetic gene clusters. The 
epoxyketone proteasome inhibitors epoxomicin and eponemycin are naturally produced by 
actinomycete bacteria, and whole genome sequencing revealed their genetic underpinnings 
and native resistance mechanism. This work represents the first elucidation of biosynthetic 
gene clusters for epoxyketone proteasome inhibitors. Chapter 3 takes a wider lens to examine 
an understudied group of bacteria: the rare marine actinomycetes. Whole genome sequencing 
of a group of rare marine actinomycetes revealed an incredible wealth of biosynthetic 
potential and diversity not yet represented in current sequencing databases. This study 
establishes rare marine actinomycetes as a group worthy of further exploration for genome 
mining and drug discovery. Chapter 4 investigates a more complex system with a focus on yet 
to be cultured cyanobacterial sponge symbionts. Previous work showed that the genomes of 
these symbionts contained the genes necessary to produce environmentally relevant poly-
brominated diphenyl ethers (PBDEs). In assembling high quality draft genomes of two 
symbionts of distinct sponges, their full secondary metabolite potential was revealed. 
Additionally, genome mining led to the identification of two novel dysinosin molecules, 
representing the first example of mining for gene clusters in a metagenome assembled 
genome leading to new chemistry.  
1 
 
Chapter 1: Introduction to the Dissertation 
1.1 Natural Product Discovery Before the Genomic Age 
1.1.1 Twentieth Century Advances in Understanding DNA  
As the blueprint of life, deoxyribonucleic acid, or DNA, is the defining molecule that 
connects biological functions and chemical entities. Understanding this simple and elegant 
molecule has spurred innumerable scientific advances. The more we learn about DNA, the 
more we uncover about the biological underpinnings of how life thrives and the chemical 
complexity that accompanies all life. The discovery of the structure of DNA, the technologies 
developed to sequence it, and the computational advances to understand these sequences pave 
the way for discoveries in all fields of science. In the field of microbial natural products, the 
coupling of DNA sequence and chemical elucidation has greatly expanded scientists’ capacity 
to discover and predict bioactive small molecules. The sequencing revolution has come at a 
particularly opportune time for the natural products field. As microbial resistance to 
antibiotics accelerates, and discovery of novel compounds from nature slows due to re-
isolation of known compounds, new approaches are necessary for continued fruitful discovery 
of bioactive molecules from the natural environment. Integrating genomic methods into 
traditional chemical isolation of natural products has already opened up new chemical and 
biological spaces to explore and exploit in the search for the next generation of anti-infective 
molecules. It is clear that the evolution of DNA sequencing, from understanding the structure 
and composition of DNA, to sequencing one gene at a time, to sequencing full genomes and 
complex metagenomes, has mirrored the evolution of natural product chemical discovery in 
the age of DNA.  
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While the significance of DNA in all disciplines of science seems to be relatively 
recent, scientists have long been seeking the truth about life’s building blocks. The second 
half of the nineteenth century is when some would say the field of cellular biology was 
established. Biological thought was shifting from studying whole organisms to studying the 
component cells that make up all living things. Charles Darwin and Alfred Wallace’s theory 
of evolution, published in 1858, introduced the idea of favorable traits being passed down 
from one generation to the next by an unknown hereditary substance
1
. Shortly after, in 1865, 
Gregor Mendel demonstrated the laws of hereditary transmission of traits with pea plants
2
. In 
1869, Swiss physician Friedrich Miescher at the University of Tübingen would accidentally 
precipitate nuclein, and describe, for the first time, the basic physical and chemical properties 
of DNA
3
. Miescher’s astonishing discovery would go largely forgotten and overlooked as the 
hereditary substance for over seventy years. Proteins were considered the likely culprit as the 
hereditary substance, as DNA was considered too simple to code for the complexity of all life. 
In 1928, bacteriologist Frederick Griffith postulated that the “transforming principal” was 
responsible for converting Streptococcus pneumoniae from a nonvirulent form with a rough 
appearance to a virulent form with a smooth appearance. In his classic experiment, Griffith 
injected live, nonvirulent, rough cells and dead, virulent, smooth cells into the same mouse. 
Soon after, the mouse died and Griffith recovered live, smooth, virulent cells from the 
mouse’s blood. Griffith concluded that there must be a “transforming principle” that would 
transform the nonvirulent strain into a virulent strain, and again all bets were on protein
4
. 
Immunologist Oswald Avery was intrigued by Griffith’s experiments, and set out to 
ultimately identify the transforming material. Along with Colin MacLeod and Maclyn 
McCarty, Avery published their results in 1944 which repeated Griffith’s experiments, 
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reported methods to isolate and purify the active transforming material, and produced data to 
show that the active fraction was not made up of protein, unbound lipid, or polysaccharides, 
but consisted solely of DNA
5
. This momentous discovery was muted at the time, and many 
scientists still believed that more complex proteins must be the transforming substance, not 
simple DNA. Alfred Hershey and Martha Chase were able to definitively show that DNA was 
indeed the inherited material using viral DNA labeled with radioactive phosphorous and viral 
protein labeled with radioactive sulfur. The resulting progeny, made by infecting bacterial 
cells, were either phosphorus labeled or not labeled, showing that only the DNA was passed 
down through the generations of viruses
6
. The elusive hereditary material that Miescher 
isolated almost a century earlier finally had a proven identity: DNA. Although the study of 
DNA had a slow start since its discovery, Avery’s experiments thrusted the simple molecule 
into the forefront of scientific exploration. Soon, the ultimate determination of the structure of 
DNA, the molecule once thought too simple to encode all of life’s nuances, would launch the 
age of molecular biology in the second half of the 20
th
 century
7-9
.  
The evolution of human understanding of DNA, from an uncharacterized, yet clearly 
novel substance, to the realization that four nucleotides can code for all of life, to finally 
solving the double helix structure set the stage for a new scientific era: the sequencing 
revolution. This progression from an accidental discovery to gradually uncovering attributes 
of DNA to having a full picture of what DNA and its purpose is, parallels the evolution and 
acceleration of natural product chemical discovery and understanding over the same time 
period. While natural products have been purposefully used for millennia, only in the last 
century have researchers begun to understand where natural products come from, how to 
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discover new ones, and why nature makes such useful molecules, again setting the stage for a 
renaissance in natural product discovery in the age of DNA sequencing.   
1.1.2 Natural Products as Medicines in the Twentieth Century 
While cellular biology enjoyed a golden age in the nineteenth century, the chemistry 
of natural products has long been exploited by humans. The earliest records of natural 
substances being used as medicinal aids come from Mesopotamia circa 2600 B.C. on 
cuneiform tablets that documented oils from Cypress and myrrh species. The ancient 
Egyptians and Chinese also documented pharmacological use of plants as drugs
10
. Until the 
advent of modern medicine, however, bioactive natural products remained locked up inside 
plant tissues, and so traditional healers would often make a paste or concoction containing the 
parts of the plant found to have healing properties. Perhaps the first natural product extracted 
from a traditional source of medicine is morphine. In 1803, Pharmacist Freidrich Serturner 
isolated morphine crystals from the long used poppy flower for the treatment of pain
11
. 
Traditional medicines are almost singularly from plants and while they were fairly well 
documented by many disparate cultures, knowledge about the true origin of the healing 
powers of these plants only began to be uncovered in the late nineteenth to early twentieth 
century, concurrent with the unraveling of the truth about the structure and purpose of DNA.  
Natural product discovery is normally done by collecting samples from nature, 
extracting them and testing the extracts in bioactivity assays. Further fractionation of the 
extract, followed by more bioactivity assays ultimately leads to a compound or suite of 
compounds responsible for the bioactivity. Chemical structure elucidation then follows 
utilizing a host of analytical chemistry technologies, such as tandem mass spectrometry 
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(MS/MS), high pressure liquid chromatography (HPLC), and nuclear magnetic resonance 
(NMR). This traditional method is often lengthy and expensive, sometimes taking years to 
chase a bioactivity, and even longer to elucidate the molecule’s structure. It is also limited by 
the amount of source material collected from nature. This is especially a problem for marine 
natural products, as many of the sources from the marine environment are not able to be 
grown or kept in the lab, and are often collected from distant places with little re-accessibility. 
Yet despite these challenges, natural product discovery thrived even prior to the discovery of 
the structure of DNA. Natural product discovery flourished during the Golden Age of 
Antibiotics, spurred by the discovery of the first natural products extracted directly from 
microbes in the mid-20
th
 century. However, by the late 20
th
 century and extending into the 21
st
 
century, many pharmaceutical companies have significantly cut down or eliminated their 
natural product programs
12
. This lull in the focus on natural products in the search for new 
drug leads is in part due to a high rate of re-discovery of already known natural products, 
supply problems that often extend the time required to develop a natural product into a 
pharmaceutical, and advances in combinatorial chemistry making synthetic approaches 
attractive
10
. However, natural products remain the best leads for drugs. Nature produces more 
structural and chemical diversity than any synthetic library of molecules and has provided the 
basis for over 70% of approved drugs from 1981 – 201013. The DNA sequencing revolution, 
and especially the advent of whole genome and metagenome sequencing, along with 
improved molecular biology and chemistry techniques, is ushering natural product discovery 
into a new Golden Age. 
 The Golden Age of Antibiotics was built on a strong foundation of the burgeoning 
field of microbiology. In the late 1800s, scientists like Louis Pasteur and Robert Koch 
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pioneered the science of studying microorganisms, and began to realize their prevalence and 
importance in disease. Before the turn of the century, bacteriologists had isolated the 
microbial agents that cause a multitude of diseases, including leprosy, the first human disease 
to be linked to a bacterium; anthrax; tuberculosis; cholera, and many more
14,15
. Emile Roux 
and Alexandre Yersin are the first to show that a disease, namely diphtheria, is caused by a 
toxin released by the bacterium Cornyebacterium diphtheria by using a filtrate of the cells 
that kills laboratory animals
16
. Once the connection between pathogen and disease was well 
established, many physicians and scientists sought to cure these diseases caused by 
microscopic organisms. Vaccination had been established at the turn of the 18
th
 century with 
Edward Jenner’s vaccine for smallpox, and now armed with the knowledge that some diseases 
caused by microorganisms could be cured with vaccines, 19
th
 century bacteriologists made 
vaccines using attenuated cultures of the disease causing bacteria
17
. This method of using a 
weakened bacterium as prevention for bacterial infection flourished in the early 20
th
 century, 
but none thought that live bacteria would ever be weaponized against disease causing 
bacteria.  
 In 1929, Alexander Fleming reports his serendipitous observation of Penicillium mold 
lysing the Staphylococcus variants he had been studying
18
. He ascertained that the mold 
produced a bacteriolytic substance, or ‘mold juice’ that diffused into solid and liquid media. 
With this happenstance observation, Fleming had observed one of the first beneficial uses of 
microbes. However, like with many groundbreaking discoveries in the history of science, his 
discovery was greeted with little enthusiasm. That is, until World War II necessitated the use 
of Fleming’s ‘mold juice,’ which he named penicillin, to treat scores of infected soldiers19. 
Howard Florey and Ernst Chain followed up on Fleming’s discovery and were able to finally 
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isolate appreciable amounts of penicillin from the fermentation broth of Penicillium, just in 
time for its widespread use in World War II
20
. This heroic effort represents the first isolation 
and production scale up of a microbial chemical for use in human medicine, setting the stage 
for decades of use of natural products as medicine.  
  While penicillin fought in the trenches, the urgent pursuance of more antibiotics was 
at the forefront of medicine. A puzzling genus of bacteria would answer the call and become 
the most prolific genus of bioactive molecule producers. First described in 1875 by Ferdinand 
Cohn, Streptothrix fosteri appeared to be different from bacillus structures known at the time 
and reminiscent of branching fungal hyphae. Cohn could not isolate and grow the elusive 
microbe, but the related causative agent for tuberculosis, Mycobacterium tuberculosis, was 
isolated and extensively studied by Koch in 1882. Decades later, in an attempt to classify 
these strange microbes, or Actinomycetes, Selman Waksman and Arthur Henrici invented the 
name Streptomyces (meaning “twisted fungus”) to apply to one group of branched microbes 
with spores produced in chains
21
. Despite classifying these microorganisms within the group 
of Actinomycetes, Waksman and Henrici still could not decipher if Actinomycetes were 
bacteria, fungi, or something in between. Waksman continued to study these indiscernible 
microbes in the search for an agent produced by a soil microbe that could be used to kill other 
pathogenic bacteria. Waksman’s use of soil microbes was by design: he had established the 
field of soil microbiology as a discipline and in 1923, before Fleming’s Penicillium 
observation, recorded that “Certain actinomycetes produce substances toxic to bacteria… 
around an actinomycete colony, upon a plate, zone is found free from bacterial growth”22. 
Waksman’s interest in antibiotics was re-awakened with the importance of penicillin during 
wartime and the emergence of the first bacterial natural product, tyrothricin, discovered by his 
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former student, René Dubos
23
. Waksman decided to target gram-negative organisms, as they 
were not killed by penicillin or tyrothricin, and chose Escherichia coli as the target cell. After 
months of adding E. coli to soil pots and recording decreased numbers of living E. coli cells 
until there were none left living, the soil was plated, and about half of the cultures obtained 
were able to inhibit the growth of E. coli. One such actinomycete was selected, grown in 
culture, extracted with solvent, and in collaboration with the leader of chemistry at Merck, 
crystals of actinomycin revealed a potent antibiotic
24,25
. Waksman’s team rapidly discovered 
streptothricin, fumigacin, and clavacin from actinomycetes, but it was soon discovered that 
these first antibiotics were toxic to animals
23
. The breakthrough came in 1944, when Albert 
Schatz, another graduate student of Waksman, discovered an antibiotic produced by a strain 
of Actinomyces griseus (later reclassified as Streptomyces griseus), the first type strain of the 
genus. Schatz named the antibiotic streptomycin and found that it killed gram-negative 
pathogens, while retaining little toxicity in animals
26
. Physicians lost no time in testing 
streptomycin as a treatment for tuberculosis, and within a year they were able to show that 
streptomycin was an active and promising drug in the treatment of tuberculosis
27,28
. This rapid 
progression from discovery to clinic was astonishing and highlighted the dire need for 
antibiotics at the time. Waskman’s astute realization that soil bacteria were constantly at war, 
and would surely make chemical means of defense, precipitated the fruitful field of 
actinomycete natural products. The following years saw the discovery of a multitude of 
antibiotics from actinomycetes: tetracycline from Streptomyces aureofaciens in 1945, 
chloramphenicol from Streptomyces venezualae in 1947, erythromycin from Streptomyces 
erythraea (later renamed Saccharopolyspra erythraea) in 1949, vancomycin from 
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Amycolatopsis orientalis in 1953, and rifamycin from Streptomyces mediterranei in 1957 to 
name a few
29
. 
 The Golden Age of Antibiotics launched microbial natural products as a productive 
field, with scientists isolating and characterizing hundreds of molecules for human use in 
medicine. The natural products field matured from one of folklore to one of directed chemical 
discovery and application. Fortuitously, advances in understanding and sequencing DNA, 
molecular biology techniques, and medicinal chemistry coincided with the rise of natural 
product discovery and development, resulting in greater understanding of nature’s molecules. 
The role of genetic manipulation and genomic information would accelerate this endeavor and 
reveal unanticipated mysteries encoded in the genomes of microbial life.   
 
1.2 Connecting Genes and Molecules  
1.2.1 Early Genetic Tools in Streptomyces for Connecting Genes and Molecules 
With the discovery of DNA’s importance in shaping all life and the maturation of 
microbiological techniques, it wasn’t long until scientists began probing the genetics of 
microbes. Naturally, Streptomyces, already known to be a prolific antibiotic producer, became 
the workhorse for genetic manipulation development in Actinomycetes. Genetic 
recombination in Streptomyces was first reported in 1955 by Sermonti and Spada-Sermonti, 
and was born of the need to understand these peculiar microbes, still not definitively classified 
as bacteria or fungi
30
. At the time, these ambiguous microbes caught the attention of at least 
five other groups that had started to genetically probe Streptomyces
31
. The husband and wife 
Sermonti team developed a fruitful collaboration with the young David Hopwood at the John 
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Innes Centre, who would become the leading pioneer of Streptomyces genetics. Hopwood set 
about the daunting task of illuminating the genetics of Streptomyces and chose Streptomyces 
coelicolor A3(2) because it produced a bright blue pigment that he thought would make for a 
valuable genetic marker, but he wouldn’t know just how valuable for another few decades. 
Hopwood set out to make a linkage map of S. coelicolor A3(2) using his invention of the four-
on-four cross method, where two parents each have two markers, one which is selectable and 
one non-selectable
32
. The recombinant progeny colonies could be plated on four selective 
media to select for the selectable parental markers, while retaining the non-selected marker. 
Using this method, Hopwood constructed the first relative linkage map, which had six loci in 
two linkage groups, in his PhD thesis at Cambridge in 1958, and expanded on it the next 
year
31,33
. Hopwood would go on to further elaborate this linkage map throughout the 1960s, 
which would in turn facilitate the first studies to connect genes and molecules in 
Streptomyces.  
The 1970s saw perhaps the most important advances in understanding Streptomyces 
genetics that would inform natural product biosynthesis, resistance, and regulation in 
Streptomyces. The first genetic tool for connecting genes and molecules was mutation, and 
with Hopwood’s linkage map, these mutations could be mapped to the S. coelicolor genome. 
Hopwood and colleagues were able to show that the biosynthetic genes responsible for 
making methylenomycin A in S. coelicolor A3(2), and the genes responsible for resistance to 
the antibiotic were present on an unusual plasmid, SCP1. A series of mutations on this 
plasmid led to a lack of antibiotic synthesis and transfer of the wild type plasmid into two 
other Streptomyces species induced production of methylenomycin A in these non-producing 
strains. Furthermore, the mutated plasmids that lost the ability to produce methyenomycin A 
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were transferred to non-producing strains, which retained resistance to the antibiotic even 
though production was absent
34-36
. This represents the very first genetic localization of 
antibiotic biosynthesis genes, and many thought that this case, namely the location on a 
plasmid, would be the norm. Ironically, methylenomycin A remains an outlier in terms of 
where the gene cluster resides
31
. Hopwood and colleagues concurrently showed that the 
biosynthetic genes for actinorhodin, the blue pigmented molecule that drew Hopwood to S. 
coelicolor in the first place, were present as “several closely linked chromosomal genes 
controlling its synthesis”37. This was perhaps one of the first mentions of biosynthetic genes 
being clustered in a bacterium’s genome, which Hopwood later went on to reiterate after 
further mutation studies in the actinorhodin biosynthetic gene cluster, and thus the idea of the 
“biosynthetic gene cluster” was born38. It would be almost ten years later that mutational 
cloning analysis would confirm this suspicion, and determine that the resistance, regulatory, 
and production genes for methylenomycin are present on a contiguous 17kb region of the 
SCP1 plasmid
39
. These are the first two examples of the connection of biosynthetic genes to 
the antibiotic molecules that they make. Although they may seem rudimentary now, mutation 
studies were one of the first genetic tools to link biosynthetic genes to natural products 
produced by bacteria. 
The most significant advances in connecting genes and molecules, however, would 
come in the 1970s with the advent of gene cloning methods, polymerase chain reaction (PCR) 
amplification, and DNA sequencing. Recombinant DNA technology was first developed in E. 
coli, with the discovery of restriction enzymes that could cut and re-join DNA at a specific 
sequence, often a palindromic sequence
40,41
. Soon after, many independent groups isolated 
DNA ligases, which have the ability to assemble two pieces of DNA together, and the first 
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recombinant DNA molecules were made in 1972
42
. Now that making recombinant DNA had 
been established, getting bacteria to take it up would be the next challenge. It was originally 
believed that E. coli was recalcitrant to transformation, but in 1970, it was demonstrated that 
treating E. coli with calcium chloride induced uptake of DNA
43
. This phenomenon was 
exploited to decisively transfer, for the first time, genes conferring antibiotic resistance, 
residing on a plasmid, to sensitive E. coli strains
44
. One year later, in 1973, the very first 
recombinant DNA had been introduced by transformation into E. coli, launching the field of 
synthetic biology. Foundational work by Okanishi and colleagues in 1974 elucidated the 
necessary factors for protoplast formation and regeneration in Streptomyces, thus allowing for 
genetic manipulation and transformation of DNA into Streptomyces hosts
45
. Others expanded 
on this protoplast formation protocol to establish an efficient plasmid transformation 
protocol
46
 as well as protoplast fusion protocols
46,47
. These first genetic manipulation tools for 
use in the most prolific antibiotic producers in nature set the stage for a flurry of genetic 
experiments to connect antibiotic biosynthetic genes to their molecules. 
In 1980, multiple groups reported the first instances of gene cloning in Streptomyces. 
These first cloning experiments purposefully focused on antibiotic resistance genes, which 
had recently been used to make the first antibiotic selectable cloning plasmid, pBR322, in E. 
coli in 1977
48
. Use of antibiotic resistance genes as selectable markers on plasmids was a 
foundational invention, facilitating the establishment of molecular cloning systems and 
protocols that are still modern gold standards. Mervyn Bibb, having completed his PhD in 
Hopwood’s lab, was successful in cloning the gene encoding resistance for methylenomycin 
A, making the first antibiotic-selectable plasmid vector for use in Streptomyces
49
. Shortly 
after, researchers in Hopwood’s lab cloned the resistance genes for neomycin and 
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thiostrepton, resulting in more selectable plasmids for use in cloning
50
. Additionally, 
Streptomyces promotor regions were isolated and for the first time it was recognized that 
“genus or species-specific factors may present barriers to the expression of bacterial genetic 
material in certain heterologous cellular environments,” an astute observation that researchers 
are still exploring today
51
.  These early advances laid the foundation for exploring antibiotic 
biosynthesis in Streptomyces. In 1983, the first gene directly involved with the biosynthesis of 
an antibiotic was cloned, allowing for comparison between two related pathways. 
Undecylprodigiosin, a red pigment produced by the ever fertile S. coelicolor A3(2), is 
structurally similar to the red pigment, prodigiosin, produced by Serratia marcescens. Using 
co-synthesis studies with blocked mutants, already established in S. marcescens, and red 
mutants generated in S. coelicolor, the authors were able to ascertain that the redE gene is 
likely an O-methyltransferase. The redE gene was cloned into plasmid pIJ702 and re-
introduced to a S. coelicolor strain with a mutation in the redE gene. This restored production 
of the methylated undecylprodigiosin, and a methyltransferase activity assay showed a level 
of methylation was restored to the wild type levels
52
. The authors clearly stated that their 
motivation for cloning the first biosynthetic gene was to lay the groundwork to further 
understand genetic control of secondary metabolite production, and perhaps begin to 
manipulate antibiotic biosynthetic pathways. Subsequent studies were published that same 
year for cloning biosynthetic genes from the methylenomycin A pathway
53
 and the candicidin 
pathway
54
, accelerating the connections of genes to molecules, and furthering understanding 
of the biosynthetic genes responsible for natural products. What these early studies couldn’t 
do, however, was reveal the true nature of antibiotic pathways. While foundational and 
necessary to establish molecular cloning in actinomycetes, these first single gene studies 
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looked mainly at resistance factors and tailoring genes, missing the meat of a biosynthetic 
pathway. The paradigm of modular assembly line pathways remained hidden in the genomes 
of antibiotic producers.   
1.2.2 Cloning Entire Pathways and the First Unnatural Natural Product 
It didn’t take long to go from cloning one or two genes to cloning the first whole 
antibiotic biosynthetic pathways. Again the famous blue pigment antibiotic, actinorhodin, was 
back in the spotlight. Labeled acetate feeding studies had previously determined that the 
molecule derived from the polyketide pathway, as had been previously shown for similar 
antibiotics, nanaomycins, naphtocyclinon, and granaticin, but no one knew yet what the 
polyketide pathway looked like genetically and biochemically
55
. A series of mutants, each 
blocked in the act pathway at different points, were mapped and determined to be in the same 
segment of the S. coelicolor chromosome, making this cluster of genes a good candidate for 
capturing the entire pathway for actinorhodin. Random pieces of DNA 15-30 kb long were 
cloned into a S. coelicolor mutant that lacked production of actinorhodin. Out of about 8,000 
transformants, two produced the characteristic blue color. The isolated plasmids were 
introduced into S. coelicolor mutants and each plasmid complemented some of the mutants, 
but neither restored production in all mutants, suggesting that the whole cluster had not yet 
been captured. This prompted the authors to create a third plasmid with the two overlapping 
portions of the act biosynthetic gene cluster. The resulting plasmid restored actinorhodin 
production in all S. coelicolor mutants and a non-producing heterologous host, Streptomyces 
parvulus
56
. This seminal work informed and inspired decades of molecular cloning and 
heterologous expression of biosynthetic pathways to this day.  
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Further work with the actinorhodin gene cluster resulted in the creation of a hybrid 
antibiotic, which is still an elusive feat in synthetic biology today. Specific segments of the 
act gene cluster were cloned into a plasmid vector that was then introduced into Streptomyces 
sp. AM-7161, which makes medermycin (a brown pigment). With the appearance of a purple 
pigment, Hopwood who had teamed up with American chemist Heinz Floss and Japanese 
microbiologist Satoshi Omura noticed they had generated a new chemical entity in this hybrid 
strain, representing a “‘cooperation’ between gene products in the actinorhodin and garaticin 
pathways.”57 The new polyketide molecule was isolated and named mederrhodin A, a 
compound with structural features from both medermycin and actionorhodin. Interestingly, 
when the whole actinorhodin pathway was introduced to the medermycin producer, only 
medermycin and actinorhodin were detected. This cutting edge application of genetic tools to 
produce a hybrid compound is astonishing, especially because it was done “blind,” without 
the guide of sequence information. The first Streptomyces gene was sequenced in 1983 by 
Charles Thompson of the John Innes Centre and Gary Gray of the Swiss pharmaceutical 
company Biogen, but widespread use of this new technology was sparse. The first 
Streptomyces gene sequence, an aminoglycoside phosphotransferase (aph) from the neomycin 
producer S. fradiae ATCC 10745 and also an antibiotic-resistance gene, hinted at the power 
that genomic sequencing would have to influence the understanding of antibiotic biosynthesis 
across domains of bacteria. It was in the comparison of the S. fradiae aph to other sequenced 
aph genes that the promise of DNA sequencing was realized, that evolutionary comparisons 
could be made between homologous genes to infer structure and function
58
. In 1988, the actIII 
gene, already deduced by mutation studies to play a role in actinorhodin polyketide chain 
modification but not chain assembly, was sequenced and revealed to be a putative 
16 
 
oxidoreductase by comparison to dehydrogenase genes in Klebsiella aerogenes and 
Drosophila melanogaster
59
.  
Concurrent to the explosion in techniques and tools to connect biosynthetic genes to 
their molecules, namely in the fruitful Streptomyces genus, was an expansion of general 
molecular biology tools, usually born from fundamental scientific research into bacterial 
enzymes. In studying antibiotic production and native resistance, the natural products 
community contributed to one of the most widely used techniques still today: molecular 
cloning. Exploitation of antibiotic resistance genes as selectable markers and the use of 
restriction enzymes and ligases isolated from E. coli led to sophisticated vector design and 
development. The following basic science developments, namely DNA sequencing and the 
invention of the PCR, would revolutionize all fields of science and particularly inform 
antibiotic biosynthesis in its nascent years.  
1.2.3 DNA Sequencing Revolutionizes Natural Product Biosynthetic Understanding 
Like most impactful discoveries in science, DNA sequencing had a slow start. It 
progressed from amino acid sequencing of a protein, to simple RNA molecules, and finally 
provided the first DNA sequences decades later. Frederick Sanger began his storied career in 
sequencing in 1951 through a series of heroic efforts to systematically hydrolyze and 
chromatographically separate pieces of the insulin protein to finally piece together the 
sequence of amino acids
60
. Protein sequencing flourished throughout the 1950s and 1960s, 
creating the first collection of sequence data, hinting at the databases of sequence information 
yet to come. Although proteins may seem intuitively more complex than DNA, they proved 
easier to sequence because the similar, repeating nucleotides that make up long DNA chains 
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made it more difficult to distinguish between one nucleotide and another. RNA was the next 
logical step in the effort to sequence, as they were short sequences, unencumbered by a 
complementary strand, and readily abundant
61
. The first whole nucleic acid sequence, an 
alanine tRNA from Saccharomyces cerevisiae, was completed in 1965 by Robert Holley and 
colleagues, using RNase enzymes, analytical chemistry, and selective ribonuclease 
treatments
62
. This process took five people working for three years with one gram of material, 
resulting in 76 nucleotides. Simultaneously, Sanger was developing a “fingerprinting” method 
based on the detection of radioactively labeled RNA fragments and subsequent visualization 
in two dimensions
63
. The subtle complexities of DNA would still evade capture by sequence 
for some years, and would require creative solutions to solve the first sequences. 
The first twelve DNA bases were sequenced using DNA polymerase and primer 
extension in 1968
64
, and another method converting DNA to ribonucleic acid (RNA) and 
sequencing those fragments decided twenty-four bases in two years
65
. These early methods 
were not scalable, and it wasn’t until 1977 that two methods were reported that could decode 
hundreds of bases, transforming this budding field practically overnight. Both methods used 
the distance from a radioactive label to the position of a base within a molecule of DNA. 
Sanger’s method, the chain terminator procedure, involved four extensions of a labeled 
primer, each with a small amount of a known chain-terminating nucleotide, thus producing 
different length fragments, depending on where the chain-terminating nucleotide was 
incorporated
66
. Gilbert’s method relied on a terminally labeled DNA restriction fragment, 
chemically fragmented at specific bases
67
. In both techniques polyacrylamide gels were used 
to determine the lengths of each DNA fragment, down to the single base pair resolution. 
While these techniques were used in labs around the world, it wouldn’t be for another decade 
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that the first commercially available, automated sequencing machine would be introduced. In 
the meantime, strategies, such as “shotgun sequencing” of random clones, followed by 
sequence assembly using overlaps began amplifying the uses of DNA sequencing
68
. By 1982, 
with the establishment of GenBank, a central repository for all sequence information, over 
half a million bases had been deposited, and a year before the first commercial sequencers 
were introduced, in 1986, almost ten million bases were in Genbank
69
.  
1.2.4 DNA Sequencing Informs Polyketide Synthase (PKS) Pathway Understanding 
In natural product research, DNA sequencing would fundamentally inform the 
biosynthesis of different classes of antibiotics and ultimately aid in the discovery of new 
bioactive molecules from nature. Perhaps the first groundbreaking development in 
understanding antibiotic biosynthesis using sequencing came from the seemingly simple 
polyketide pathway that could make an incredibly diverse structural range of products with 
widespread functions. In 1989, cloning and sequencing the pathways for granaticin and 
tetracenomycin C, the first bacterial polyketide synthase (PKS) structures studied by 
molecular genetics, revealed that the PKS genes are indeed similar in sequence and 
organization to fatty acid synthases (FASs), as had been postulated based on biochemical 
studies
70,71
. In both studies, the acyl carrier proteins (ACPs) were also identified using 
sequence homology, and suggested that different ACPs are utilized in fatty acid and 
polyketide biosynthesis. Overall, both studies concluded that they had sequenced PKS gene 
clusters, homologous to FAS type II gene clusters from primary metabolism, consisting of 
separate subunits, which turns out to be the rule for aromatic, or type II polyketide synthases. 
Subsequent studies on the sequence of the erythromycin biosynthetic gene cluster in 
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Saccharopolyspora erythraea revealed an unexpected second group of polyketide 
biosynthetic genes, previously only known in eukaryotes: type I PKSs. Erythromycin was 
found to be made not by discrete enzymes encoded by different genes, but instead by large, 
multi-modular proteins consisting of all the necessary domains for constructing the polyketide 
backbone
72
. Remarkably, sequencing revealed that multiple modules of domains were present, 
forming what is now commonly referred to as assembly line PKS biosynthesis
73
. For almost a 
decade after the discovery of type I PKS pathways in bacteria, researchers believed there were 
only type I and II PKS systems in bacteria, but again, DNA sequencing would reveal 
otherwise. In 1999, two groups reported sequencing and characterizing bacterial genes that 
showed homology to chalcone synthase and stilbene synthase genes, previously known only 
in plants
74,75
. In both cases, the type III PKS molecule structures were known, but only after 
genome sequencing was the underlying mechanism for their assembly elucidated. A fourth 
type of PKS pathway emerged from DNA sequencing data in 2002, when two groups 
concurrently discovered a new type of PKS system. Jörn Piel noticed a lack of committed 
acyltransferase (AT) domains in each module in the gene cluster for pederin. Instead, two AT 
domains are present upstream of the cluster that can act in trans, servicing all the 
ketosynthase (KS) domains in the cluster
76
. Simultaneously, Ben Shen cloned the pathway for 
leinamycin and documented the “AT-less” nature of the pathway77,78. These findings 
represent the first characterization of trans-AT PKS pathways, which are now known to be 
quite widespread in nature, especially in understudied taxa
79
.  
Only through sequence analysis and comparison could the underlying mechanisms of 
trans-AT, type I, II, and III PKS biosynthesis be observed. In the case of type II PKS systems, 
gene sequence directly informed the programming of these assembly line gene clusters, 
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effectively allowing researchers to ‘read’ the construction of a PKS through each module, 
hinting at the predictive powers to come in PKS biosynthesis
80
. These advances in 
understanding iterative and assembly line PKS systems further opened the door to informed 
combinatorial biosynthesis with the ambition of making unnatural natural products. 
While the first combinatorial antibiotic had been made in 1985, it was done so in a 
fairly random manner. Armed with gene sequence information, Chaitan Khosla’s lab at 
Stanford, in close collaboration with David Hopwood, set about performing directed 
combinatorial studies that would successfully produce unnatural natural products, while 
providing new insights into the key features of these programmable enzymes. In 1993, they 
found that ACPs were interchangeable, carbon chain length is dictated by a chain length 
factor (CLF) particular to type II PKSs, and that a given ketoreductase (KR) can recognize 
and reduce different lengths of polyketide chains, among other things
81
. Khosla and 
colleagues soon devised a set of design rules for the directed manipulation of PKS assembly 
lines by genetic engineering. They used their rational design to produce two new PKS 
molecules using natural enzymatic subunits from multiple PKS pathways to obtain the desired 
molecules
82
. These studies also introduced the idea of the ‘minimal PKS,’ consisting of a KS, 
ACP, and CLF, which was the starting point for designing new PKS molecules. Just before 
the turn of the century, KOSAN Biosciences manipulated the erythromycin pathway to 
produce a library of over 50 macrolides, a feat that would be impractical to pursue using 
synthetic chemistry and one that would prove that informed design based on sequence 
information was worth pursuing
83
. Soon researchers could pick and choose particular 
structural features to gain certain functions in their designer molecules, and the advent of 
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whole bacterial genome sequencing would provide even more insight into the biochemical 
pathways and regulation of these pathways encoded in bacterial genomes
84
. 
1.2.5 Patterns in NRPS Domain Architecture Unveiled by DNA Sequencing 
Gene sequencing momentously advanced our understanding of PKS pathways in 
bacteria in ways that wouldn’t have been possible without DNA sequencing. Parallel to the 
unravelling of PKS pathways, understanding of non-ribosomal peptide synthetase (NRPS) 
pathways was being revealed by DNA sequencing as well. Foundational work by Fritz 
Lipmann had shown that NRPS pathways were already known to encode large, multi-enzyme 
complexes with a multi-domain structure (as was shown by sequencing for type I PKSs), but 
gene sequencing still had more to reveal about NRPS pathways
85
. The first nucleotide 
sequence of a gene in an NRPS pathway was for the tycA gene, encoding the tyrocidine 
synthase from Bacillus brevis, and was reported in 1988 by Mohamed Marahiel’s group, but it 
wouldn’t be until the next NRPS genes were sequenced that comparative insights could be 
gleaned
86
. In 1990, the acvA gene, initiating penicillin biosynthesis in Penicillim chyrsogenum 
Oli13, was sequenced and showed homology with the B. brevis tycA gene. While the authors 
recognized that the function of these enzymes is unknown, the similarity between discrete 
domains within genes known to encode enzymes that adenylate amino acids led them to 
speculate that homologous domains within acvA also activate amino acids. In fact, the authors 
note that the presence of three such domains may adenylate three amino acids in the resulting 
penicillin structure
87
. Further studies go on to elaborate the role of adenylation (A) domains in 
peptide synthetases, definitively showing a link between these repetitive domains and the 
amino acids selected for in the final product
88-91
. Gene sequencing went on to reveal an NRPS 
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gene with an N-methyl-transferase domain, previously uncharacterized
92
. In 1999, the first 
bioinformatic tool for predicting A domain specificity was developed. Marahiel, Stachelhaus 
and colleagues used the recently solved crystal structure of the gramicidin synthetase 
phenylalanine activating A domain, PheA, to compare residues lining the binding pocket with 
the corresponding moieties in other A domains
93
. They were able to construct general rules 
for predicting A domain substrate specificity using in-silico studies and structure-function 
mutagenesis
94
. This so called Stachelhaus code provides one of the greatest predictive tools in 
NRPS biosynthesis still today, and provides the basis for many A domain bioinformatic 
prediction tools discussed in section 1.3.4.  
Another tool for connecting NRPS genes with molecules exploited the repetitive, 
highly homologous nature of NRPS genes. Degenerate primers were designed by sequence 
comparisons of domains from the gramicidin, tyrocidine, and penicillin synthetases. PCR was 
then utilized to successfully amplify the previously unidentified surfactin peptide synthetases 
from Bacillus subtilis ATCC 21332
95
. The authors went on to establish this method as a 
useful protocol for reliably finding NRPS genes in known peptide antibiotic producers, and 
perhaps in unknown producers as well
96
. This method was used in a wide variety of 
cyanobacteria and showed that many of the strains tested, whether they produced a toxin or 
not, contained PCR amplifiable regions of NRPS genes, hinting at the silent gene clusters that 
whole genome sequencing would soon reveal
97
. Early comparative sequence analysis allowed 
for the development of these important tools that would play an active role in discovering new 
NRPS molecules.  
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Peptide synthetase gene sequence analysis first revealed the highly repetitive A 
domains as a common feature of NRPS genes, and soon other patterns would emerge from the 
DNA sequences. Distinct domains were consistently observed upstream of A domains, with 
the exception of the loading module, and were speculated to be condensation (C) domains, 
playing a role in peptide elongation. This n-1 domain pattern (where n = the number of A 
domains) corresponded to the number of peptide bonds in a given NRPS molecule, bolstering 
the identity of these domains as C domains
98
. Another class of genes, the new superfamily of 
phosphopantetheinyl (P-pant) transferases, determined to be necessary for non-ribosomal 
peptide synthesis, were discovered through sequence comparisons by Christopher Walsh’s 
lab. The first P-pant transferase to be sequenced was the E. coli ACPS, involved in fatty acid 
biosynthesis, but surprisingly, initial searches of sequence databases did not turn up any 
proteins with significant homology
99
. However, after refining sequence alignments, two 
shared motifs emerged in several putative ACPS homologs. This sequence alignment and 
comparison led to the discovery of a large family of proteins, putatively P-pant transferases. 
Walsh, Khosla, Marahiel and colleagues went on to characterize these proteins, confirming P-
pant transferase activity
100
. This elegant example shows how comparative sequence analysis 
can reveal biosynthetic mysteries that may not have been uncovered otherwise.  
The examples discussed here are by no means comprehensive, but they do show the 
vast impact that gene sequencing had on understanding, predicting, and manipulating natural 
product biosynthesis. Up until this point, however, only single genes or gene clusters had been 
utilized in the quest to understand natural product biosynthesis at the genetic level. Most early 
gene sequencing studies focused on known secondary metabolites, which informed the 
sequencing projects to connect them to genes responsible for assembling them. These studies, 
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while foundational for understanding natural product biosynthesis, yielded few new molecular 
entities, with the exception of the innovative combinatorial biosynthesis studies, but the full 
promise of DNA sequencing would soon fill this gap. Coming developments in DNA 
sequencing technologies to allow for economical whole genome sequencing would greatly 
expand the success in natural product biosynthesis initiated by gene sequencing efforts, and 
even lead to a new mode of discovery of natural products from environmental microbes.  
 
1.3 Genome Mining in the Twenty-first Century 
1.3.1 Sequencing Phylogenetic Tags Exposes the Uncultured Majority of Microbes 
The seemingly small progression from sequencing genes to genomes propelled our 
understanding of natural product producing organisms to new heights. Early whole genome 
sequencing was a lengthy process, expensive, and accessible to only a few large sequencing 
centers
101
. With the introduction of the first commercial Sanger sequencing machines in 1987, 
single gene sequencing flourished, but to sequence a whole genome was a momentous task. 
Sanger sequencing, as it relied on gel electrophoresis to read each base, was not a high-
throughput initiative. It would take eight years after the first commercial sequencing machines 
were released for a bacterial full genome sequence to be reported. In 1995, the roughly 1.8 
Mb genome of Heomophilus influenza was sequenced and reported by Robert Fleischmann 
and colleagues, followed closely by the report of the 0.58 Mb genome of Mycoplasma 
genitalium by Craig Venter’s group102,103. In the following decade, about 300 sequenced 
bacterial genomes would be published
101
. Because of the cost and labor, whole genome 
sequencing languished behind the invention of the first commercial DNA sequencer. Instead, 
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it was much more common to sequence single genes and sometimes stretches of a 
chromosome, as was seen in the natural product biosynthesis community. Other researchers 
sought to use sequencing as a way to probe the environment for microbial diversity, revealing 
an astonishing abundance of unknown, uncultured microbes, which would prove to be a 
promising avenue in natural product discovery. 
Genetic tools to classify and analyze the phylogenetics of microbes were established 
by the mid-1980s, with the use of ribosomal RNA sequencing, specifically the conserved 
marker 16S rRNA
104
. Scientists used this method to show a huge abundance and diversity of 
uncultured microbes in soil communities
105
, extremophilic host-spring environments
106,107
, 
and marine environments, including hydrothermal vent-associated symbionts
108
 and pelagic 
bacterioplankton communities
109,110
. These biodiversity profiling studies established the 
phenomenon of the ‘uncultured microbial majority,’ with uncultured species vastly 
outnumbering cultured ones. Large numbers of 16S rRNA sequences began populating 
GenBank in 1996 as the techniques for 16S rRNA profiling became commonplace
111
. These 
studies brought recognition to the untapped reservoir of diverse environmental microbes and 
potential for novel natural product chemistry, giving rise to the field of metagenomics. 
Metagenomics of soil organisms was of particular interest, and the idea to clone 
environmental DNA from soil into cultivatable microbes and subsequently screen for new 
chemistry allowed, for the first time, access to previously inaccessible biosynthetic 
pathways
112
. The search for novel natural products had helped establish an entirely new 
discipline and just as the unseen majority of microbes was beginning to be appreciated, so too 
was the hidden majority of biosynthetic gene clusters locked up in microbial genomes. 
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Actinomycetes, especially the genus Streptomyces, had long been lauded for their 
abilities to produce an abundance and variety of natural products. Gene sequencing allowed 
for an in depth look into the biosynthetic pathways of known metabolites and hinted at the 
ability to find new natural products using degenerate primers and gene probes based on 
known PKS or NRPS sequences. Sequencing of whole biosynthetic pathways allowed for 
common features and patterns to emerge from the data, even discovering a whole new 
superfamily of proteins. But what researchers would find in the first genomes of antibiotic 
producing Streptomyces would change the course of natural product discovery.  
1.3.2 Whole Genome Sequencing Reveals Abundance of Cryptic Gene Clusters 
The workhorse of actinomycetes, Streptomyces coelicolor A3(2), with multiple 
antibiotics already isolated and many biosynthetic pathways characterized, was the first 
antibiotic producer to be sequenced in its entirety. The behemoth of a bacterial genome, 
greater that 8.6 Mb and containing the largest number of genes discovered yet in a bacterium, 
revealed over twenty predicted gene clusters encoding known and predicted secondary 
metabolites. The gene clusters responsible for actinorhodin, CDA, and the whiE grey spore 
pigment had been analyzed previous to the whole genome sequencing effort, but the presence 
of at least eighteen uncharacterized gene clusters containing hallmarks of secondary 
metabolism was unanticipated. Newly developed bioinformatic tools at the time aided in 
predicting two NRPS gene clusters responsible for making the siderophores coelichelin and 
coelibactin
113
. The structure of coelichelin was the first natural product to be predicted solely 
based on genomic sequence information, giving rise to the field of genome mining
114
. The 
remaining gene clusters in the complete S. coelicolor A3(2) genome sequence were able to be 
27 
 
putatively identified, some with predicted molecular products, and at least classified into the 
type of molecule they would make, again establishing the reach of genome mining in 
identifying the ‘silent majorty’ of cryptic gene clusters.  
The next sequenced Streptomyces species, was the industrially important S. 
avermitilis, producer of the antiparasitic avermectins. The S. avermitilis genome was revealed 
to be slightly larger at 9.0 Mb, and was shown to contain thirty gene clusters related to 
secondary metabolite biosynthesis, with this specialized function comprising 6.6% of the 
genome
115
. Previous reports of genome sequence of this organism identified 25 secondary 
metabolite gene clusters, but with complete sequencing, 5 more were revealed
116
. The authors 
predicted the structures for some of the metabolites encoded and experimentally confirmed 
production of geosmin, pentalenolactone, squaliene, and pentaene, all predicted from genome 
sequence. A comparative genomics approach revealed a higher similarity between S. 
coelicolor and S. avermitilis than with other whole genome sequenced organisms, including 
two strains of M. tuberculosis, E. coli, and B. subtilis. The two Streptomyces genomes were 
shown to have 69% similarity in their genes, with unique ORFs largely coding for proteins 
implicated in secondary metabolism, transcriptional regulation, transposition, and degradation 
of xenobiotics. Despite high similarity in the two genomes, interesting differences arose. For 
example, both Streptomyces species are resistant to chloramphenicol, but it appeared that S. 
coelicolor gained resistance through efflux pumps shown in other Actinomycetes to confer 
resistance, but S. avermitilis lacked these pumps yet had a chloramphenicol 
phosphotransferase, which was shown to confer resistance in the chloramphenicol producer, 
S. venezuelae. Furthermore, it was noted that many secondary metabolite biosynthesis genes, 
including those for producing antibiotics, were not conserved between the two species
115
. This 
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observation was particularly salient and more strains of the same genus sequenced would 
begin to show this to be true between strains of the same species.  
S. coelicolor and S. avermitilis had been extensively studied, their genetics probed for 
decades, and yet the startling discovery that their genomes had so much more to offer 
prompted a renewed search for natural products using genome mining. With new ways to 
access unculturable bacteria and the observed abundance of silent, or cryptic, gene clusters the 
biological and chemical spaces to discover new natural products greatly expanded. The 
invention of massively parallel, high throughput genome sequencing gave scientists the tools 
to explore the previously inaccessible spaces. Genomic data trickled in during the age of 
Sanger sequencing, even the first full genomes were few and far between, but soon, the 
invention of next-generation sequencing technologies would create a deluge of genomic data. 
1.3.3 Next-Generation Sequencing Leads to Explosion in Sequence Data 
Sanger sequencing proved to be a reliable method for getting reasonably long 
sequence reads, and continues to enjoy widespread use today. However, Sanger sequencing 
would reach a limit in terms of output, as it relies on gel electrophoresis to read each base, 
using, at most, 384 well capillary machines
101
. An old invention in DNA sequencing would 
solve this limit, creating a new wave of next-generation DNA sequencers. The basis for the 
method, called pyrosequencing, took advantage of one of the byproducts of DNA synthesis: 
the release of a pyrophosphate molecule as each nucleotide is incorporated. The release of 
pyrophosphate could be detected using a two-enzyme process, which uses ATP sulfurylase to 
convert pyrophosphate into ATP, which is in turn used as the substrate for luciferase
117
. 
Exploitation of this natural chemical transformation in DNA synthesis led to a sequencing 
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approached where a template DNA is affixed to a surface, nucleotides are washed over the 
template, and if a base is added, light can be detected
118
. Although both Sanger sequencing 
and pyrophosphate sequencing are sequencing by synthesis models and they were developed 
around the same time, some advantages of pyrosequencing allowed it to be developed into the 
first major successful commercial sequencing technology. First, expensive, modified dNTPs 
used in chain-termination methods were not required, and natural bases could be used. 
Second, the process can be observed in real-time, unlike the lengthy gel electrophoresis 
readout of Sanger sequencing
119,120
. Pyrosequencing was licensed to 454 Life Sciences where 
it was developed into a machine with the capability to sequence highly parallelized samples, 
massively increasing the amount of DNA that could be sequenced in one fell swoop
121
. This 
paradigm shift re-defined how DNA sequencing is used in experiments, leading to an 
abundance of whole genome sequences and launching multiple initiatives to sequence DNA 
cheaper and faster
122-126
. For a complete review of next-generation sequencing technologies, 
see “Coming of age: ten years of next-generation sequencing technologies” by Goodman, 
McPherson, and McCombie
127
.  
The cost for DNA sequencing continues to drop throughout the 21
st
 century with 
faster, easier, and cheaper methods for sequencing available to almost all labs all over the 
world. In fact, the capability of DNA sequencers has surpassed the rate observed in the 
‘computing revolution’ described by Moore’s law: the number of transistors per unit cost 
doubles about every two years. DNA sequencing capacity, between 2004-2010, doubled every 
five months
128
. This democratization of sequencing has driven a ‘genomics revolution’ that 
the natural products community has enthusiastically taken part in, with the promise of genome 
mining delivering multiple new chemical entities from predicting sequence data.  
30 
 
1.3.4 Computational Tools Help Predict Natural Products 
With new access to unprecedented amounts of DNA sequence data, the natural 
product community set out to characterize the ‘bacterial dark matter’ hidden within the 
genomes of bacteria. Bioinformatic tools have been instrumental in making the abundance of 
data manageable and meaningful. One of the most impactful tools for deducing gene function 
by homology is the National Center for Biotechnology Information’s (NCBI’s) Basic Local 
Alignment Search Tool (BLAST)
129
. Genbank, introduced in 1982, was the first public, 
central repository for genomic sequence data, and eventually, with the amount of sequence 
data building up, a method to search it and compare sequences was necessary. Additionally, 
researchers were beginning to notice patterns in the sequences of biosynthetic gene clusters of 
secondary metabolites, which could be used to make sets of rules for predicting the class of 
secondary metabolite and even structural features of the resulting molecule. One of the first 
tools developed examined 102 glycosyltransferases from 52 biosynthetic gene clusters to 
correlate sequences of glycosyltransferases to their structures and corresponding substrates
130
. 
SEARCHGTr would highlight the power of comparative genomics of many genes carrying 
out similar reactions. Another early tool, NRPSPredictor, was made into a freely available 
online webserver, designed to predict A domain specificity in NRPS gene clusters
131
. 
NRPSPredictor was first made available in 2005, when widespread full genome sequencing 
was still in its infancy. The tool was updated and improved in 2011 after more bacterial NRPS 
sequences became available and was expanded to predict fungal A domain specificity
132
. 
Since NRPSPredictor, a host of other online tools have been developed to predict substrate 
specificity of NRPS and PKS pathways, including: NRPSsp
133,134
, NRPS/PKS substrate 
predictor
135
, PKS/NRPS Web Server
136
, LSI based A-domain function predictor
137
, SEQL-
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NRPS
138
, and PKSIIIexplorer
139
. All of these tools relied on the comparison of thousands of 
sequences to ultimately achieve high confidence prediction, a feat unfeasible before the 
introduction of next-generation sequencing. 
While DNA sequencing showed early on that NRPS and PKS pathways contained 
patterns that made substrates straightforward to predict, ribosomally synthesized and 
postranslationally modified peptides (RiPPs) had been notoriously difficult to computationally 
identify
140
. RiPP gene clusters can be very small and have no universally shared signature 
genes, making them difficult to find
141
. With these caveats in mind, the Kuipers group set 
about making a tool to locate putative bacteriocin, or RiPP, pathways. Their resulting 
program, BAGEL, uses RiPP databases to identify motifs and takes into account the genomic 
context so that genes accessory to the core RiPP assembling genes can inform the location of 
such gene clusters
142,143
. Another early effort manually searched, using PSI-BLAST for 
homologues of the LanM lanthipeptide dehydratase/cyclase using the sequence of ltnM1 from 
the lacticin cluster
144
. This strategy revealed 89 strains containing homologues, 61 of which 
were not known lanthipeptide producers. These efforts resulted in the isolation of lichenicidin, 
a novel antibiotic
145
. 
Perhaps the most widely used computational tool by natural product researchers today 
is antiSMASH
146-148
. First developed in 2011, antiSMASH is a user-friendly web tool that 
identifies over 40 types of known secondary metabolite classes. It identifies and annotates 
secondary metabolite gene clusters and gives rudimentary structural predictions. This holistic 
software utilizes many standalone tools for an integrated analysis, including MultiGeneBlast 
(MGB)
149
, Natural Product Domain Seeker (NaPDoS)
150
, multiple A domain predictor 
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software mentioned previously, and ClusterFinder
151
. MGB is a standalone program that 
allows similarity searches for cassettes of multiple genes and is useful for determining if a 
gene cluster is similar to others in sequenced organisms. antiSMASH also uses MGB to 
compare identified gene clusters to characterized gene clusters in the minimum information 
about a biosynthetic gene cluster (MIBiG) database
152
. MIBiG is a curated database of 
experimentally validated biosynthetic gene clusters that is especially useful for dereplicating 
clusters that make known molecules and identifying clusters similar to characterized ones that 
might make a structural variant of a known molecule. NaPDoS also utilizes characterized KS 
and C domains to phylogenetically clade input KS and C domains, classifying them and 
predicting the kind of chemical transformations they can perform. ClusterFinder can address 
one of the shortcomings of antiSMASH: predicting noncanonical biosynthetic pathways. 
While antiSMASH is very good at identifying known classes of biosynthetic gene clusters (ie 
PKS, NRPS, RiPPs, terpenes, etc), its algorithms rely on the genomic underpinnings of these 
cluster types. ClusterBlast, however, can pick out putative clusters by identifying genes that 
are usually involved in secondary metabolism biosynthesis, but may not belong to a class of 
biosynthetic gene cluster. Another shortcoming of antiSMASH is the crude structural 
predictions provided. PRISM (Prediction informatics for secondary metabolomes) was 
introduced in 2015 to create combinatorial structure predictions for NRPS and PKS gene 
clusters
153
. The structural predictions take into account the permutation of monomers utilized 
in the structural skeleton and the variability in the action of tailoring enzymes to provide a 
library of possible structure predictions from a given NRPS or PKS biosynthetic gene cluster. 
A recent rebuild of the software expanded the cluster types it can predict, widening its scope 
to twenty-two distinct natural product cluster types
154
.  
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Software prediction and identification of secondary metabolite biosynthetic gene 
clusters has greatly improved over the last few years, and with the deluge of genomic data, 
prioritizing gene clusters for further study has become an urgent endeavor. One method of 
prioritization is to look for clusters that might make molecules with new molecular targets. 
Often, bacteria will make a natural product that has a cellular target and must avoid suicide 
while making such a toxic molecule. One way to do this is to have a duplicated copy of the 
target that is mutated in such a way that confers resistance to its own inhibitor. An elegant 
example of this is seen in the producer of the potent proteasome inhibitor, salinosporamide A. 
Salinispora tropica, a marine-obligate actinomycete, makes salinosporamide A, a proteasome 
inhibitor, and possesses proteasome machinery. The biosynthetic gene cluster encoding 
salinosporamide A also contains a duplicate copy of the gene coding for the beta-proteasome 
subunit that salinosporamide A attacks. This accessory beta-proteasome subunit has a 
mutation that confers resistance not only to salinosporamide A, but other proteasome 
inhibitors as well
155,156
. Co-localizing the biosynthesis of the resistant target with the 
biosynthesis of the inhibitor is an efficient way to ensure self-resistance. These duplicated, 
often mutated cellular targets provide the opportunity for target-directed genome mining
157
. A 
recently developed software tool, the antibiotic resistant target seeker (ARTS) utilizes this 
concept to identify duplicated, phylogenetically incongruent housekeeping genes localized to 
secondary metabolite biosynthetic gene clusters
158
. This tool is one of the first to provide a 
logical basis for gene cluster prioritization based purely on bioinformatics, and more tools like 
this will be necessary as the surge in genomic information shows no signs of slowing.  
1.3.5 Integrating Genomic and Metabolomic Data 
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A powerful way to utilize genomic information for predicting secondary metabolite 
structures and dereplicating, or removing redundant, known structures is to couple it with 
metabolomics data. These methods were first developed for peptide natural products. One of 
the first developments in this field was the introduction of natural product peptidogenomics 
(NPP), a mass spectrometry (MS) guided genome mining method connecting peptides 
detected in tandem MS experiments to their biosynthetic gene clusters
159
. NPP was able to 
characterize ten diverse peptides using this method of matching observed amino acid 
fragment masses with expected amino acids from A domain predictions, and served as an 
early proof-of-concept for automating genome mining by integrating metabolomic data. 
Multiple tools followed, including Pep2Path
160
, which succeeded in automating peptide 
genome mining pioneered by NPP; cycloquest
161
, a tool for matching cyclopeptides to their 
gene clusters; iSNAP
162
, an informatics search strategy  developed for NRPS dereplication; 
and glycogenomics
163
, for quick characterization of glycosylated natural products and relation 
to their corresponding gene clusters. These early specialized tools gave way to more 
comprehensive tools, such as the genomes to natural products (GNP) platform, which utilizes 
high-throughput MS/MS data and genomic information to connect NRPS and PKS molecules 
to their gene clusters
164
. Recently, the first retro-biosynthetic program was introduced as a 
method to connect known molecules to their unknown biosynthetic gene clusters. The 
generalized retro-biosynthetic assembly prediction engine (GRAPE) and the global alignment 
for natural products cheminformatics (GARLIC) endeavor to connect known chemical entities 
to their gene clusters and aid in the discovery of new molecules from orphan gene clusters
165
. 
Bioinformatic tools (for a more comprehensive list see the Secondary Metabolite 
Bioinformatics Portal at http://www.secondarymetabolites.org/) have greatly increased the 
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productivity of genome mining the vast amounts of genomic data available today. Although 
exact structural predictions solely from genomic information are still not feasible in most 
cases, integration of easily acquired MS/MS data have helped in connecting observed 
molecules to sequenced gene clusters. Bioinformatic tools have also aided in the dereplication 
process that is necessary to deprioritize known molecules and prioritize novel chemical 
scaffolds. One overall deficit in bioinformatic predictions of natural products is the caveat that 
we can only find what we’re looking for; that is, completely new classes of molecules with 
unknown underlying genetic basis will be missed by these bioinformatic tools. While 
ClusterFinder seeks to address this issue, it often identifies so many putative clusters that 
sifting through and prioritizing them can remain a daunting task. Biochemical characterization 
of enzymes performing new types of chemistries will surely aid in the discovery of new 
classes of bioinformatic gene clusters. Additionally, wide-scale genomic comparisons of gene 
clusters from thousands of bacterial genomes can aid in uncovering more secrets from 
bacterial genomic dark matter.  
1.3.6 Large Scale Analyses of Bacterial Genomes Reveal a Wealth of Undiscovered 
Biosynthetic Gene Clusters 
 With bacterial whole genome sequencing relatively commonplace, the secondary 
metabolite potential, diversity, and distribution in cultured microbes are being revealed on a 
large scale. Just as the need to prioritize gene clusters has become paramount, the task of 
cataloging and surveying the biosynthetic capacity of the natural world has become a focus of 
attention. As previously mentioned, the MIBiG database
152
 filled an important void in the 
cataloging of characterized gene clusters and their corresponding molecules. Likewise, the 
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Joint Genome Institute (JGI) has curated the Integrated Microbial Genomes—Atlas of 
Biosynthetic gene Clusters (IMG-ABC)
166
 which contains over a million putative biosynthetic 
gene clusters identified using ClusterFinder. Such large repositories dedicated to secondary 
metabolism biosynthetic gene clusters are helping to dereplicate characterized gene clusters 
and better explore the vast majority of uncharacterized gene clusters. One of the first large 
scale analyses of genomes from talented secondary metabolite producers came from over 75 
sequenced genomes of Salinispora spp. strains
167
.  Ziemert and co-workers found a high level 
of pathway diversity among these strains with 99% sequence identity for the 16S rRNA gene. 
Of the 124 distinct “operational biosynthetic units” (OBUs), only nine had characterized 
natural products associated with them. Furthermore, species specific OBUs were found for the 
three defined Salinispora species, but the majority of OBUs appeared as singletons, residing 
in only one or two strains. This clustering of similar pathways into OBUs represents one of 
the first methods for grouping similar gene clusters that likely make similar products.  
New methods have emerged for relating similar gene clusters through gene cluster 
family networks. Multiple groups have now developed algorithms to score gene cluster 
similarity and group them into gene cluster families based on these scores. The first such large 
scale analysis was published in 2014 and examined 1,154 genomes spanning the prokaryotic 
tree
151
. This wide-ranging analysis unveiled a surprising finding that the largest gene cluster 
family in current sequence databases is responsible for producing aryl polyene carboxylic 
acids. Additionally, this gene cluster family network utilized ClusterFinder to identify gene 
clusters of both known and unknown classes. By using a non-restrictive algorithm for gene 
cluster designation, they were able to identify the presence of large network families that 
contained widely distributed gene clusters without any characterized members, the largest of 
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which was found to encode aryl polyene carboxylic acid biosynthesis. This kind of global 
analysis is foundational not only for identifying and defining the genetic underpinnings of 
new classes of secondary metabolites, but also for prioritizing biosynthetic gene clusters for 
experimental characterization.  
 A more focused approach was taken in a gene cluster family network analysis of 830 
actinomycete genomes, including 344 newly sequenced genomes for this study
168
. In addition 
to focusing only on actinomycetes, the study also used a narrowed down list of gene cluster 
types concentrating on NRPS, type I and II PKS, RiPPs, and thiazole-oxazole modified 
microcins. Another layer of validation was added to this gene cluster family network by using 
MS detection of known molecules and correlating them to their gene clusters. Their method 
was able to link previously unassigned gene cluster families to known molecules, aiding in 
dereplication and identification of structurally similar congeners. Networking gene cluster 
families with a focus on a particular class of molecules has revealed that the capacity for 
making such molecules is much more diverse than what has been presently characterized. For 
example, a gene cluster family network of lanthipeptide-like biosynthetic pathways in 
actinomycetes found that lanthionine synthetases are genetically much more diverse that was 
previously thought
169
. Another study examined more than 10,000 actinomycete genomes for 
their ability to make phosphonic acid natural products
170
. This large scale analysis found that 
there are 64 distinct gene cluster families, of which 55 are likely to produce unknown 
compounds. This study went further to elucidate eleven previously undescribed phosphonic 
acid natural products.  
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 Another recent gene cluster family algorithm was developed using the prolific Moorea 
genus of cyanobacteria. Leao and coworkers developed BioCompass, a new method that 
allows for similarity scoring of subclusters, which recognizes and takes advantage of the 
modular nature of many natural product gene clusters
171
. Moorea proved to have an 
astonishing amount of secondary metabolite biosynthetic potential, with up to a quarter of its 
genome dedicated to secondary metabolism. The BioCompass gene cluster family network 
revealed that 59% of the pathways found across four Moorea sp. strains have homology only 
to other Moorea clusters, highlighting the uniqueness of these strains. While there is no 
standard method for genome mining or producing gene cluster family networks, a recently 
published chapter on such protocols can help guide the identification, classification, and 
creation of gene cluster family networks for exploring large volumes of genomic 
information
172
. One advantage of gene cluster family networks is incorporating information 
from databases, such as MIBiG, to determine if previously characterized clusters exist in such 
a network
171,173
. This kind of dereplication can aid in prioritizing unknown clusters. 
Furthermore, gene cluster family networks can reveal the true scope of the biosynthetic 
potential represented in our sequenced databases. In most cases, the diversity sequenced has 
not begun to approach saturation, suggesting that much more novelty will be seen as we 
sequence more rare taxa from underexplored habitats. Some of the most promising sources of 
biological and chemical diversity are hidden in environmental metagenomes and 
uncultivatable bacteria that have been widely overlooked in favor of their easily cultured 
counterparts. Metagenomic sequencing is touted as a powerful tool for examining the vast 
majority of uncultured organisms and discovering biosynthetic potential previously unknown. 
1.3.7  Metagenomic Discovery of Natural Products 
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 Metagenomics and its role in natural product discovery is a newly emerging field, 
created by the sequencing revolution. It allows for sequencing environmental samples to give 
a glimpse into the full capacity in any given environment. Previous reliance on culturing 
organisms for study in the lab is no longer necessary to examine their genomes. Additionally, 
metagenomic sequencing has brought about the burgeoning field of microbiome studies, 
which are increasingly seen as productive systems for natural product discovery
29
. In 
particular, studying the human microbiome has accelerated the recognition of bacterial 
communities and their specialized chemistry
174,175
. Natural products have been and continue 
to be isolated from the human microbiome
176
. Furthermore, microbiome communities can 
give insight into chemical bacterial interactions, including elicitation of specialized chemical 
signals. Metagenomic sequencing and the study of diverse microbiomes has opened 
previously inaccessible biological spaces to explore new and functionalized chemistry. 
Just as whole genome sequencing of the well-studied Streptomyces spp. revealed a 
wealth of orphan biosynthetic gene clusters, metagenomic sequencing of environmental 
samples exposes the vast majority of unculturable microbes in the environment and their 
potential for secondary metabolite production. Soils were the first complex metagenomes 
realized for their potential in the search for new bioactive molecules. Before metagenomic 
sequencing of environmental DNA became commonplace, clone libraries made directly from 
environmental samples, soil for example, were tested for bioactivity and then the individual 
clone could be sequenced
112
. This allowed for the first metagenomic exploration of 
environmental samples before the advent of high-throughput sequencing and yielded new 
natural products
177-179
. Not long after this approach was applied to complex soil samples, 
researchers drew comparisons to the complex microbiomes seen in symbiotic systems, such as 
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the diverse microbial communities seen in sponges
180
. The depth of sequencing coverage 
needed for uncultivatable microbes was recognized as a caveat early on, and enriching for a 
dominant symbiont prior to DNA extraction was suggested as a partial solution to this 
problem. Methods for combining short insert libraries used for shotgun sequencing to 
identifying secondary metabolism genes and large insert clone libraries used to screen with 
the identified sequences were developed prior to economical high-throughput 
sequencing
181,182
. These early clone library based methods were used to identify and express 
the first cryptic gene clusters from metagenomic samples
76,183-185
. 
 With the advent of affordable, widespread high-throughput sequencing, whole 
metagenome or microbiome sequencing has recently become feasible. Metagenomic 
sequencing is especially powerful in exploring symbiotic animal systems, which have 
provided an enormity of natural products, but sample size and supply limitations have largely 
limited them to academic study rather than pharmaceutical applications
186,187
. Directly 
sequencing metagenomic DNA from a lichen assemblage revealed that the cyanobacteria 
member of the symbiosis contained the first trans-AT PKS cluster seen in cyanobacteria
188
. 
Direct metagenome sequencing of a marine tunicate and its microbiome yielded the gene 
cluster responsible for making the important anti-cancer drug, Yondelis
189
. The discovery of 
the biosynthetic basis for this pharmaceutically important molecule paved the way for direct 
production of the drug and opened the possibility for metabolic engineering through pathway 
manipulation. Metagenomic sequencing of three Dysideidae sponges, known both for their 
abundance of poly-brominated diphenyl ether (PBDE) molecules and their signature 
cyanobacterial symbiont, revealed the cyanobacterial biosynthesis of PBDEs
190
. The pathway 
for producing the structurally related pentabromopseudilin had just been described and was 
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used, in part, as a query for the PBDE pathway
191
. Using a biosynthetic hook to search for 
similar aspects of biosynthesis can be especially useful in examining complex metagenomes. 
This study also highlights the increasingly feasible practice of de novo assembly of microbial 
genomes from metagenomes
192-195
.  
Often, metagenomes are so complex that assembly of any one genome from the 
metagenome is virtually impossible without ample sequencing depth, and the result will 
inevitably be a population genome. The invention of Multiple Displacement Amplification 
(MDA) and improvement of the process allowed DNA from single cells to be amplified and 
sequence for the first time
196,197
. This kind of selective amplification provides a nice 
complement to whole metagenome sequencing. A filamentous cyanobacteria assemblage was 
queried using MDA on a single cyanobacteria cell and metagenomics library screening to 
locate the gene cluster responsible for apratoxin
198
. This kind of hybrid approach was also 
used to assemble the genomes of the uncultivated Entotheonella spp. inhabiting Theonella 
swinhoei sponges
199
. MDA from isolated cells and metagenome sequencing of the whole 
sponge resulted in a genome for the novel endosymbiont, shown to have immense capacity for 
secondary metabolite production. Equipped with advanced tools like MDA, genome assembly 
from metagenomes, large insert clone libraries, heterologous expression and whole genome 
metagenome sequencing, researchers are finally beginning to dive past the tip of the iceberg 
when it comes to microbial natural product potential in the environment.  
As the cost of sequencing continues to fall, the abundance of genomic information 
from previously intractable systems will open access to immense new biosynthetic potential. 
Symbiotic assemblages harboring yet uncultured symbionts are especially promising avenues 
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for new natural product potential. Underexplored environments, now available to exploration 
through metagenomic sequencing, will also surely yield novel biochemical transformations. 
We are truly at the cusp of another Golden Age for natural product discovery, facilitated by 
the explosion in genomic sequencing information and exposing the dark matter hidden inside 
microbial genomes, one base at a time.  
1.4 In This Dissertation 
1.4.1 Chapter 2: Genetic Basis for the Biosynthesis of the Pharmaceutically Important 
Class of Epoxyketone Proteasome Inhibitors 
Figure 1. Chapter 2 Overview 
The gene clusters for epoxomicin and eponemycin were located in their respective producer’s 
genomes and heterologously expressed. Molecular networking revealed multiple structural 
congeners produced by the eponemycin gene cluster. 
 
This published chapter (Schorn, M et al. ACS Chem Biol, 2013)
200
 consists of the first 
report of biosynthetic gene clusters for epoxyketone proteasome inhibitors, as determined 
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through whole genome sequencing and heterologous expression. In this study, the genomes of 
two expoxyketone proteasome inhibitors were sequenced using the Ion Torrent PGM with a 
modified protocol for improvement of high G+C content DNA sequences. The genomes were 
interrogated to elucidate the putative biosynthetic gene clusters for epoxomicin (epx) and 
eponemycin (epn). Two hybrid NRPS/PKS gene clusters with A domain specificities 
matching the amino acids contained within epoxomicin and eponemycin were chosen for 
subsequent heterologous expression studies. Additionally, the eponemycin gene cluster 
contained a second copy of the gene encoding the beta-proteasome subunit, a known 
resistance factor for proteasome inhibitors in actinomycetes
155
. The epoxomicin producer also 
contained a second copy of the beta-proteasome subunit in a different region of the genome. 
These two gene clusters were selected for heterologous expression. The pathways were cloned 
using a Fosmid Library approach. The libraries were screened using primers designed to 
probe for regions of the gene cluster. Two clones were identified, each containing the epx and 
epn gene clusters in their entirety. The pathways were then integrated into a host strain, 
Streptomyces albus J1074, using triparental intergenic conjugation. The host strains with 
integrated epx and epn clusters were fermented and extracted, and the resulting extracts 
analyzed using HPLC. New peaks corresponding to epoxomicin and eponemycin were 
identified while comparing to the empty host strain. Additional molecular networking of the 
empty S. albus and S. albus + epn revealed a number of related analogues present in small 
amounts. This initial report of the biosynthetic gene clusters for the pharmaceutically 
important epoxyketone proteasome inhibitors laid the foundation for interrogating the 
mechanism of formation for the epoxyketone warhead. This study also introduced the use of 
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betaine in Ion Torrent sequencing sample preparation for improved high G+C sequences 
characteristic of actinomycetes.  
1.4.2 Chapter 3: Sequencing Rare Marine Actinomycete Genomes Reveals High 
Density of Unique Natural Product Biosynthetic Gene Clusters 
 
Figure 2. Chapter 3 Workflow 
Workflow shown for cultivating rare marine actinomycetes, subsequent sequencing and 
genome assembly and secondary metabolite gene cluster identification followed by analysis 
of secondary metabolite potential. 
 
 This published chapter (Schorn, M et al. Microbiology, 2016)
173
 surveys twenty-two 
rare marine actinomycetes for their biosynthetic potential and compares them with a 
contemporary database of sequenced actinomycete genomes. The decline in antibiotic 
discovery, concurrent with the rise of antibiotic resistance necessitates the search for natural 
products from new sources. Marine Streptomyces strains and the marine obligate genus, 
Salinispora, have proven a wealth of biosynthetic potential in marine actinomycetes, but 
strains from rare, understudied genera have gone largely unexplored
167,201-206
. Twenty two 
Ion Torrent PGM Sequencing 
SPAdes Assembly   antiSMASH Analysis  
Secondary Metabolite Potential 
15 Rare Marine  
Actinomycetes 
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non-Streptomyces, or so called rare actinomycete
207
, strains from the Fenical/Jensen marine 
actinomycete collection at the Scripps Institution of Oceanography were selected for whole 
genome sequencing using the Ion Torrent PGM. Ten strains had been previously screened 
using degenerate primers for NRPS and PKS biosynthetic genes
208
. Five additional, 
unscreened strains were chosen to widen the variety of the genera involved in the study. The 
genomes were assembled using a pre-release version of SPAdesIT from the Pevzner lab
209,210
. 
The rare marine actinomycete genomes were analyzed for the secondary metabolite 
biosynthetic potential and a variety of number and types of pathways were observed. To place 
these rare marine actinomycete genomes in the context of other sequenced actinomycete 
genomes, biosynthetic gene cluster similarity network was built. This analysis revealed that 
87% of the biosynthetic gene clusters in the twenty two genomes were not similar to any 
sequenced actinomycete gene cluster. Additionally, when compared with marine 
Streptomyces, both showed high levels of pathway uniqueness, suggesting an 
underrepresentation of marine strains in current whole genome databases. This study employs 
large-scale bioinformatic analysis to show that marine-derived genera warrant further study 
and sequencing in natural product discovery. Rare marine actinomycetes, in particular, 
represent a promising avenue for biosynthetic pathways uncaptured by current sequencing 
databases.  
1.4.3 Chapter 4: Uncultured Cyanobactierial Symbionts of Marine Sponges and Their 
Natural Products 
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Figure 3. Chapter 4 Workflow 
Overview of the workflow undertaken in Chapter 4, consisting of hybrid sequencing and 
assembly of uncultivated sponge cyanobacteria symbionts and subsequent genome mining 
and molecular networking leading to the identification of novel structures.  
 
 This final chapter describes the biosynthetic potential of and the characterized 
molecules from two Guamanian Dysideidae sponges. Previous studies of the biosynthesis of 
brominated natural products from marine bacteria
191
 and cyanobacterial symbionts in 
sponges
190
 prompted further investigation of the uncultured cyanobacterial symbionts of 
related specimens of Dysideidae sponges. The persistent cyanobacterial symbionts, well 
documented in sponges of the family Dysideidae, have been recalcitrant to isolation for 
decades
211-215
. The cyanobacterial trichomes can, however, be enriched by squeezing the 
sponge and centrifuging the exudate
212
. These cell enrichments allow for more targeted 
metagenomic sequencing using both Illumina HiSeq and PacBio RS II platforms to assemble 
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genomes with greater than 90% completion. Two symbionts, one (GUM202_hs) from a 
sponge harboring poly-brominated diphenyl ethers (PBDEs) and one (GUM007_hs) from a 
sponge that doesn’t contain PBDEs, were selected for this cell enriched sequencing and 
genome assembly procedure and their genomes interrogated for secondary metabolite 
biosynthetic potential. The hs_bmp pathway, previously characterized as responsible for the 
production of PBDEs
190
, was not present in the GUM007_hs symbiont, but was present with 
an extra putative halogenase gene in the GUM202_hs symbiont. Also observed and 
characterized were thirteen PBDEs, with higher degrees of bromination than previously 
described from the Guamanian sponges collected
190,216
. The non-PBDE producing symbiont 
from GUM007 contains an NRPS gene cluster closely related to the characterized aeruginosin 
pathway. Aeruginosin-like compounds, dysinosins A-D, have been isolated from Dysideidae 
sponges in Australia
217,218
. Bioinformatic comparison leads us to believe that the NRPS 
pathway in GUM007_hs is responsible for making a dysinosin-like compound. Comparison 
with dysinosin standards, provided by Ron Quinn at Griffith University, reveals two masses 
for putative new dysinosins. Fragmentation patterns confirm their structures, and efforts for 
isolating enough of the compounds for NMR characterization are underway. In an effort to 
understand why these microbes have yet to be cultured in the lab, the primary metabolism 
pathways were comparatively analyzed using the Synecchococcus elongates PCC 7942 
metabolic model to uncover missing genes
219
. This study demonstrates the feasibility of 
assembling uncultured symbiont genomes from metagenomes, providing a sizeable fraction of 
cells can be obtained from the host. It also exposes the biosynthetic capacity of these 
symbionts and possible reasons for their resistance to cultivation. Finally, this study provides 
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the first example, to our knowledge, of genome mining in a metagenome assembled genome 
from an uncultivatable symbiont resulting in new chemical structures.  
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2.1  Introduction to Chapter 2 
 
Figure 4. The 20S Proteasome and Proteasome Inhibitors 
The 20S proteasome is comprised of a core made up of two β-rings between two α-rings, each 
consisting of seven subunits, and a 19S regulatory particle that recognizes poly-ubiquinated 
proteins. The proteins enter the catalytic chamber where they are degraded into small peptides. 
Four natural product proteasome inhibitors (1, 2, 4, 5) and two synthetic proteasome inhibitors 
currently on the market as anti-cancer agents (3, 6) are shown. 
 
Cancer is a tenacious and devastating disease affecting an increasing amount of the 
human population. According to the World Health Organization, cancer is the second leading 
cause of death globally, with almost 1 in 6 deaths attributed to cancer worldwide in 2015
1
. Many 
current cancer treatments have harsh side effects and tumor cells have been developing 
resistance to clinical drugs, so the search for new anticancer agents is pressing. One mechanism 
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by which cancerous cells can be halted is by the inactivation of the proteasome, an essential 
protein-degradation macromolecular complex
2
.   
In eukaryotic cells, the 26S proteasome works in tandem with the ubiquitin system, 
which tags proteins with polyubiquitin chains that are recognized by the proteasome which 
proceeds with nonlysosomal protein degradation (Figure 1). The proteasome is responsible for 
90% of protein degradation in the cell. The 26S proteasome is involved in a variety of cell 
functions from DNA repair to cell cycle control to apoptosis, through its most fundamental 
purpose: irreversibly inactivating targeted proteins. This targeted degradation can be used to 
regulate concentrations of proteins within the cell. Inhibiting the proteasome has many 
medicinally relevant consequences, including cell apoptosis, anti-viral activity, anti-tuberculosis 
activity, and anti-cancer therapy. Arresting the function of the proteasome specifically 
suppresses angiogenesis, which can go unregulated in cancerous cells causing tumor growth, and 
ultimately leads to apoptosis in oncogenic cells while retaining limited toxicity to normal cells
3
. 
This large protein complex is composed of the core 20S proteasome and the 19S regulatory 
particle, both made up of multiple subunits. The 20S proteasome core is formed by stacking two 
outer α-rings and two inner β-rings, each ring made up of seven subunits. Of the 14 β subunits, 
β1, β2, and β5 have specific hydrolytic activity. The β1-subunit has caspase-like activity, the β2-
subunit has trypsin-like activity, and the β5-subunit has chymotrypsin-like activity, all with 
active sites on the inner surface of the β-rings, forming a proteolytic chamber4.  
Proteasome inhibitors (PIs) bind, via a variety of mechanisms, to the hydrolytic β-
subunits either irreversibly or reversibly. The first natural product PI, lactacystin (1), was 
isolated from a Streptomyces sp. in 1991
5
. Subsequent studies showed that at low concentrations 
of lactacystin, the eukaryotic cell cycle would be halted and at higher concentrations, would 
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causes apoptosis
6
. Further studies showed that lactacystin was selectively causing apoptosis in 
malignant cells, rather than healthy cells. This fueled the speculation that cancerous cells rely 
more heavily on proteasomal degradation than do normal cells
7
. There are eight structural classes 
of PIs, five of which have natural products among them. One example is salinosporamide A (2) 
of the β-lactone class, produced by the marine actinomycete Salinispora tropica8. It is currently 
in clinical trials, known as Marizomib, for treatment of multiple myeloma and glioma. 
Bortezomib (3) was the first PI approved by the FDA for treatment of multiple myeloma and 
mantle cell lymphoma. However, bortezomib binds reversibly, has significant side effects, and 
has developed resistance in some patients. Resistance to bortezomib was first seen in cancer cell 
lines and subsequently in patients. It was found that repeated exposure to bortezomib caused 
some cell lines to become resistant. Further studies showed an up-regulation of β-subunits and/or 
a mutation in the gene encoding for the β5-subunit found in these cell lines
9
.  
Insights into PI resistance can be gleaned by studying the biosynthetic pathways of 
actinomycetes that produce PIs, as they have functioning proteasomes and must have some 
resistance mechanism to survive. In the salinosporamide A pathway there is an extra gene, SalI, 
which encodes a mutated proteasome β-subunit. This gene is accessory to the normal proteasome 
machinery in Salinispora tropica, and when expressed will complex with the primary α-rings to 
form a proteasome resistant to salinosporamide A. It was also found to be resistant to 
bortezomib, suggesting a mutation in the substrate binding pocket. When comparing the β-
subunit S1 binding pocket protein sequence residues of multiple actinomycetes, Saccharomyces 
cerevisiae, and Homo sapiens, a mutation at position 49 is apparent. All “non-resistant” 
sequences contain an alanine at this residue, while SalI has a valine in this position. Site directed 
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mutagenesis at the 49 position confirmed that a mutation to valine causes a loss in hydrolytic 
activity
10
.  
The most specific and potent class of PIs is the α’β’-epoxyketones, which covalently and 
irreversibly bind to the proteolytically active subunits only in the proteasome, not other proteases 
in the cell. The first two PIs with this unique epoxyketone moiety were epoxomicin (4) and 
eponemycin (5), both naturally produced by actinomycetes discovered in the early 1990s
11,12
. An 
analogue of epoxomicin, carfilzomib (6), was recently approved by the FDA in July 2012 as a 
third line treatment against multiple myeloma
13
. The mechanism by which the epoxyketone 
functional group selectively binds to and halts the function of the proteasome was investigated 
using co-crystallization of epoxomicin bound to a yeast 20S proteasome. The exquisite 
specificity with which epoxyketone PIs inhibit the proteasome is explained by a six-membered 
morpholine ring formed by the opening of the epoxyketone warhead by the N-terminal threonine 
of the catalytic subunits
14
. This morpholino adduct reveals the exploitation of the 26S 
proteasome’s unusual catalytic mechanism; the free α-amino group of the threonine opens the 
epoxide to form the ring, and thus serine and cysteine proteases will not be inhibited as these 
residues do not have a free α-amino group to open the epoxide15. 
While the mechanism by which the epoxyketone binds to and arrests the function of the 
proteasome has been described, the biosynthesis of these natural products is unknown. Unveiling 
the biosynthetic pathways to assemble these molecules could enable production of large 
quantities of starting material for synthetic derivatives and precursors. Of particular interest to us 
is the assembly of the unique epoxyketone moiety and the presence of proteasome subunit 
resistance genes in the biosynthetic gene clusters encoding epoxyketone PIs. This research 
represents the identification of the first biosynthetic gene clusters for epoxyketone PIs. 
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This work has been published in ACS Chemical Biology in January 2014, Volume 9, 
Issue 1, Pages 301- 309
16
. This publication resulted from a collaboration with Dr. Leonard 
Kaysser who wrote the majority of the paper, planned the experiments with Dr. Bradley Moore, 
and carried out some of the lab work. I wrote portions of the paper and performed the majority of 
the lab work. Judith Zettler curated and submitted the genomic information to NCBI. Dr. Joseph 
Noel provided the Ion Torrent PGM machine I used to sequence the genomes. Dr. Pieter 
Dorrestein provided the LC/MS instruments used for molecular networking. 
We obtained the strains Streptomyces sp. ATCC 53904, the epoxomicin producer, and 
Streptomyces sp. ATCC 53709, the eponemycin producer and isolated genomic DNA. I then 
sequenced the two strains using the Ion Torrent
TM
 PGM with a modified protocol that I devised 
for improved sequencing with high G + C content DNA. I assembled the genomes using the CLC 
Genomic Workbench software suite. The assembled genomes were submitted to antiSMASH, 
and we identified the hybrid non-ribosomal peptide synthetase (NRPS)/polyketide synthase 
(PKS) putative gene clusters responsible for the production of epoxomicin and eponemycin. I 
then constructed two fosmid libraries using the CopyControl
TM
 Fosmid Library Production Kit. I 
screened each library using primers specific for genes within each cluster and identified a 
positive clone with the entire gene cluster intact for each fosmid library. We then proceeded to 
create integration cassettes for stable chromosomal integration into heterologous hosts, using 
triparental intergenic conjugation. Dr. Kaysser then analyzed the heterologous hosts using HPLC 
to separate the culture extracts and find the peaks representing epoxomicin and eponemycin. He 
then went on to do molecular networking of the eponemycin host to reveal various structural 
analogues produced in the heterologous host containing the eponemycin gene cluster. We found 
that the gene cluster for eponemycin contained a mutated, secondary β-subunit, and while the 
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gene cluster for epoxomicin did not contain the accessory β-subunit, there was a second, mutated 
copy elsewhere in the genome. This accessory subunit acts as the producer’s defense mechanism 
against its own toxic molecule. 
As a whole, this project provided the perfect foundation for my continuing studies on 
connecting genes and molecules in antibiotic producing bacteria. The skills I learned in this 
project lead me to develop a larger scale sequencing effort of rare marine actinomycetes to 
genome mine these underutilized taxa for the secondary metabolite potential. 
Section 2.3 is a reprint of material as it appears in “Genetic Basis for the Biosynthesis of 
the Pharmaceutically Important Class of Epoxyketone Proteasome Inhibitors” in ACS Chemical 
Biology, 2014, Schorn, M., Zettler, J., Noel, J. P., Dorrestein, P. C., Moore, B. S. & Kaysser, L.   
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3.1  Introduction to Chapter 3 
The scientific community is currently poised at an exciting inflection point with the 
escalating “democratization of sequencing.” Just a few years ago, whole genome sequencing 
was used sparingly as it was extremely expensive and labor intensive, and thus outsourced. 
Now, genome sequencing, especially for microbial genomes, is rapid, affordable and can take 
place in the lab
1
. Scientists are finding new ways to utilize the growing abundance of genomic 
DNA sequences. Bacterial whole genome sequencing is being developed as a new tool to 
discover promising novel chemicals from marine microbes by identifying specific secondary 
metabolic gene clusters using genome mining and expressing them in heterologous hosts
2
.  
The conventional path to discovering new compounds from microbes is lengthy and 
work intensive. Culturing the microbes can take weeks and a large percentage of the microbes 
from environmental samples cannot be cultured. The bioassays to detect bioactivity may be 
incomplete in the scope of natural product activities and can be time intensive. The 
downstream extraction, fractionation, and elucidation may also miss molecules not produced 
in a laboratory setting. This new era of fast, easy sequencing and synthetic biology can open 
doors to exploring microbial communities, even those uncultivatable, harboring 
unprecedented natural chemistry.  
The actinobacteria (referred to here as actinomycetes) represents a diverse phylum of 
Gram-positive bacteria with a high GC DNA content, capable of immense secondary 
metabolic capacity. They are renowned for producing biomedically important molecules, 
from antibiotics to anti-cancer compounds
3
. Actinomycetes produce about two-thirds of 
known antibiotics, with the majority discovered from the genus Streptomyces
4
. Many of the 
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more widely known prolific genera, such as Streptomyces, Mycobacterium, and Salinispora 
have been studied in depth with hundreds genomes sequenced
5
. Salinispora is arguably the 
most prolific marine actinomycete genus discovered to date, producing a suite of potent 
bioactive chemicals
6
. Lesser known marine actinobacteria have been discovered, however, 
their genomes remain largely unexplored. In their 2010 paper, Gontang and coworkers probed 
a variety of marine sediment actinomycetes, from the popular Salinispora and Streptomyces 
genera to unexploited genera such as Marmoricola and Serinicoccus, for biosynthetic 
pathways indicative of secondary metabolite production
7
. The majority of the microbes 
assayed contained either or both polyketide synthase (PKS) and non-ribosomal peptide 
synthetase (NRPS) genes, suggesting the presence of biosynthetic machinery for making yet 
unknown novel chemicals. The so called rare actinomycetes, defined by Bérdy as non-
Streptomyces actinomycetes, represent a group worthy of further exploration through genome 
sequencing and genome mining
8
.  
At the time of this project, Ion Torrent boasted the fastest and most economical 
sequencer on the market, as well as long read lengths of over 400 base pairs
9,10
. With access 
to such technology, it is possible to generate a draft genome of a bacterium within a few days. 
Actinobacteria are characterized as having high G + C content in their DNA, which is often 
hard to amplify without bias, and thus provide a problem for next-generation sequencing. In 
this project, I used the optimized sample preparation for high G + C DNA that I developed in 
the previous chapter, sequencing the proteasome inhibitor producers. A TAR cloning vector 
has been developed in the Moore lab specifically for expression of large actinomycete gene 
clusters
11
. This method is faster and more targeted than the traditional fosmid library 
construction method, which relies on random DNA shearing and probability of an intact 
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cluster being located within one fosmid. The intersection of benchtop sequencing and genetic 
engineering provides one method to go from genomic sequence to chemical product, 
bypassing traditional selective processes.  
The prospect of leaping from genomic code to molecule is fast approaching, with 
technological advances in sequencing, bioinformatics and heterologous gene expression 
paving the way to discover and manufacture unknown molecules from proposed biosynthetic 
pathways. Rare marine actinobacteria are the perfect candidates for exploration, as their 
relatives are historically rich in secondary metabolites and are relatively unstudied. 
This project has been published in the journal Microbiology in December 2016 Issue 
12, Volume 162 on pages 2075-2086
12. It was chosen as the Editor’s Choice for the December 
2016 issue. This work was planned and conceptualized by myself, Dr. Brad Moore, and Dr. 
Tommie Lincecum. I first selected 22 strains of rare marine actinomycetes from the 
Fenical/Jensen collection at the Scripps Institution of Oceanography. Five of the strains were 
isolated, described, and provided by Nastassia Patin, a member of Dr. Paul Jensen’s lab13. I 
grew each strain and isolated high molecular weight gDNA by using the Qiagen Genomic Tip 
Kit. I then prepared Ion Torrent 400bp sequencing libraries. Dr. Lincecum and Kristen 
Aguinaldo of Ion Torrent helped to optimize a thermoprofile for these difficult to sequence 
genomes.  
I originally assembled the genomes using CLC Genomics Workbench, as was done in 
Chapter 2. I was able to get basic assembly statistics and biosynthetic gene cluster 
completeness from these original assemblies, as well as determined which genomes needed 
re-sequencing. Subsequently, I established a collaboration with Dr. Anton Korobeynikov from 
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Dr. Pavel Pevzner’s lab, who was developing an improved assembly algorithm for Ion Torrent 
data, SPAdesIT
14,15
. Anton re-assembled all my genomes using SPAdesIT before the 
assembly program was released to the public. Dr. Sheila Podell performed the genome 
completeness assessment of the final assemblies to show that these genomes were indeed 
complete and of high enough quality for subsequent analysis. Mohammad Alanjary, of Dr. 
Nadine Ziemert’s lab, and I planned the bioinformatic analyses of biosynthetic gene clusters 
in all genomes. I constructed the Circos
16
 figure showing the variety and distributions of 
pathways within the rare marine actinomycetes I sequenced. Mohammad performed the 
biosynthetic gene cluster networking using a combination of custom scripts and published 
methods
17
. We then analyzed the networks and summarized the findings. Mohammad and I 
also built the 16S phylogenetic tree, placing each strain within the larger context of the 
actinomycetes. Dr. Ziemert provided guidance and suggestions for phylogenetic and 
bioinformatic analyses and Dr. Jensen provided helpful advice about growing marine 
actinomycetes and insights into their genomes.   
This highly collaborative project allowed us to reveal, for the first time, the secondary 
metabolite potential of a sliver of the rare marine actinomycetes isolated by the Jensen and 
Fenical labs. We were able to show that these taxa are underrepresented in our current 
sequencing databases, and they yield a high density of previously un-sequenced, possibly 
novel biosynthetic gene clusters. This work provides the genetic foundation and motivation to 
pursue underexplored marine actinomycetes as a source for novel compounds. 
The genome mining I performed in this project led me to pursue two biosynthetic gene 
clusters from two of the genomes from this study. I chose two gene clusters from two 
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different Nocardia isolates: strains CNB044 and CNY236. Both clusters were successfully 
captured using Transformation Associated Recombination (TAR), but downstream integration 
and expression of the clusters proved unyielding. Despite attempts to manipulate regulatory 
elements present in one cluster, no production of new compounds was ever detected. The 
results of these attempts, and the insights they provided to problems facing activation of silent 
gene clusters are discussed in the Chapter 3 Appendix. 
Section 3.3 is a reprint of material as it appears in “Sequencing Rare Marine 
Actinomycete Genomes Reveals High Density of Unique Natural Product Biosynthetic Gene 
Clusters” in Microbiology, 2016. Schorn, M. A., Alanjary, M. M., Aguinaldo, K., 
Korobeynikov, A., Podell, S., Patin, N., Lincecum, T., Jensen, P. R., Ziemert, N. & Moore, B. 
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3.5  Chapter 3 Appendix 
Genome mining the twenty-two strains described in Chapter 3 led to the discovery of 
two pathways chosen for pathway capture and expression using transformation associated 
recombination (TAR)
1-3
. Although both pathways were successfully captured using TAR, 
subsequent integration and expression in heterologous hosts was unsuccessful. These 
biosynthetic gene clusters and the attempts to express them are described here. 
1. Type 2 PKS (T2PKS10) + glycosylation genes (GLY) from Nocardia sp. CNY236  
Figure 5. Dual capture scheme for the T2PKS10+GLY gene cluster from Nocardia sp. 
CNY236 
A strategy for dual capture and integration is depicted here. The T2PKS portion of the cluster 
was captured using pCAP03, while the glycosylation and other tailoring genes were captured 
on pCAP06. The vectors are designed such that they can both be integrated in a host organism 
simultaneously. 
 
pCAP06 Vector Construction 
A T2PKS gene cluster was identified by antiSMASH
4
 and upon further inspection, 
was found to have a set of glycosylation genes putatively involved in making and appending a 
sugar group to the PKS core. Because the T2PKS portion and the neighboring glycosylation 
genes were too large for capture together (about 80 kb), we decided to capture and express 
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them separately. This approach however necessitated the design of a new capture vector for a 
double integration system (Figure 5). This new vector, named pCAP06 (Figure 6), was 
designed to work in tandem with pCAP03, as they have different antibiotic resistance markers 
and different integrase sites. pCAP06 was constructed via Gibson Assembly with three pieces. 
The first two were amplified from pCC02 (pCAP02), a first generation TAR vector, similar to 
pCC01 (pCAP01), but with apramycin resistance and the φBT1 integrase site. In order to 
incorporate the counter-selection introduced in the second generation TAR vector, pCAP03, 
the continuous URA3 and pADH site was amplified from pCAP03 using primers designed to 
have overlapping regions with the ends of the pCC02 amplified pieces. Because the 
apramycin cassette has an XhoI cut site in it, this vector cannot be digested with XhoI and 
NdeI for use in TAR. Instead, it can be amplified in two overlapping pieces and combined 
with overlapping capture arms using a three piece Gibson Assembly. 
Figure 6. Vector map of pCAP06 
pCAP06 replaces the kanamycin resistance cassette in pCAP03 with an apramycin resistance 
cassette aac(3)IV (in yellow). Additionally, the φC31 integrase is replaced with the φBT1 
integrase (in red). All other elements of pCAP03 are retained. 
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TAR capture of T2PKS and glycosylation genes and integration attempts 
The TAR 2.0 protocol
2
 was followed to capture both the T2PKS portion of the cluster 
in pCAP03 and the glycosylation genes in pCAP06. Confirmation of the captured clusters was 
verified by restriction enzyme digest. Isolated plasmids pCAP03/PKS10 and pCAP06/GLY 
were taken to the Ziemert lab at the University of Tübingen for integration and heterologous 
expression in Amycolatopsis japonica. This host strain was chosen for its closer phylogenetic 
relationship to Nocardia and it had been recently developed as a suitable heterologous host 
for Nocardia pathways
5,6
. 
A sequential integration approach was taken with the two parts of the cluster. A first 
attempt used tri-parental conjugation as described in Flett et al
7
 and mycelial conjugation as 
described by Stegmann et al
8
 for both pCAP03/PKS10 and pCAP06/GLY in A. japonica, 
kindly provided by the Evi Stegmann at the University of Tübingen. Only the pCAP06/GLY 
integration was successful in this first attempt, verified by sequencing multiple regions of the 
GLY cluster from DNA isolated from the heterologous host. Multiple subsequent attempts to 
integrate pCAP03/PKS10 into A. japonica with mycelial and spore conjugation failed. A 
possible reason was that the glycosylation portion of the gene cluster contained some 
exporters that may be necessary to transport a toxic PKS molecule out of the cell. Therefore, 
A. japonica + pCP06/GLY was prepared as a host strain for pCAP03/PKS10. Integration of 
pCAP03/PKS10 into A. japonica + pCAP06/GLY was seemingly successful by the presence 
of exconjugants after every attempt at conjugation. However, each time these exconjugants 
were screened, they contained only the GLY portion of the gene cluster, and never the PKS 
portion, yet they had resistance to both kanamycin and apramycin. The apramycin resistance 
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cassette could not be amplified from the exconjugants, suggesting possible cross resistance 
between kanamycin and apramycin. 
Replacement of kanamycin resistance with hygromycin resistance in pCAP03/PKS10 
After discussing cross resistance of kanamycin and apramycin with Leonard Kaysser 
and Bertold Gust at the University of Tübingen, it appears that cross resistance to the two 
antibiotics can occur when apramycin resistance is introduced first and then kanamycin 
resistance. That is, strains carrying apramycin resistance can also be resistant to kanamycin, 
but the opposite is not always observed. Because integration of pCAP03/PKS10 (with 
kanamycin resistance) could never be achieved, possibly due to self-toxicity issues, 
conjugation with the apramycin resistant plasmid had to occur first. To overcome this, the 
kanamycin resistance cassette was replaced with hygromycin resistance, using λ red 
recombination to “knock out” the kanamycin resistance gene, replacing it with hygromycin 
resistance. The PCR targeting protocol reported by Gust et al
9
 detailing λ RED recombination 
in Streptomyces was used. The resulting plasmid, pCAP03/hygΔkan-PKS10, was used for 
conjugation attempts in A. japonica + pCAP06/GLY. More than six conjugation attempts 
were made. Again, exconjugants grew and continued to grow after multiple re-streakings, but 
they never carried the pCAP03/hygΔkan-PKS10 plasmid. Some exconjugants began 
producing a dark blue/black pigment, but again were devoid of pCAP03/hygΔkan-PKS10. All 
plasmids and strains used in these experiments have been stored in replicates and saved at -
20°C or -80°C.   
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Future Directions 
It is puzzling that exconjugants appear after conjugation in A. japonica + GLY with 
pCAP03/hygΔkan-PKS10 and grow when re-streaked, but never contain the PKS portion of 
the gene cluster. It is possible that A. japonica + GLY has weak resistance to hygromycin, 
although tests of A. japonica WT showed no resistance to hygromycin. Future conjugation 
attempts should check for presence of the hygromycin resistance cassette in exconjugants, as 
it is possible that the plasmid is partially conjugated. Another antibiotic could be substituted 
for hygromycin, or increased amounts of hygromycin could be used. Alternatively, the PKS 
cluster is not able to integrate into A. japonica. It could be that it is too toxic to the host 
organism, and necessary resistance genes were not captured in either cluster.  
2. NRPS20 gene cluster from Nocardia sp. CNS044 
Figure 7. NRPS20 cluster from Nocardia sp. CNS044 
Figure 7 shows the NRPS20 gene cluster as identified by antiSMASH. It consists of one large 
NRPS gene with four A domains and no specificities predicted. An additional partial copy of 
the ribosomal S1 subunit is also present in the cluster (shown in a teal box) and could be a 
possible resistant target.  
 
Selection of NRPS cluster, TAR capture and initial conjugation 
A small NRPS gene cluster (~25kb) was identified by antiSMASH (Figure 7). It 
contains one large NRPS gene with four A domains with unpredictable specificities. Three 
regulators precede the cluster and are designated as PadR, TetR1, and TetR2. Upstream of the 
PadR regulator is an oxidoreductase and a standalone A domain. It also contains a duplicate 
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copy of the ribosomal S1 subunit (RS1). The ribosomal S1 subunit is not currently a target of 
any antibiotics and could be a putative resistant target if the product of this gene cluster 
encodes a ribosome inhibitor. Thus, this cluster was chosen for TAR capture and expression. 
TAR capture was successful in pCAP03 and the resulting plasmid, pCAP03/NRPS20 was 
integrated by triparental conjugation and spore conjugation as previously described into 
Streptomyces coelicolor M1152. However, HPLC analysis of the host with empty vector and 
host with pCAP03/NRPS20 did not identify any new peaks.  
Conjugation in A. japonica and regulator knock outs 
Because no production was observed in S. coelicolor M1152, integration in the more 
closely related host, A. japonica, was undertaken in the Ziemert lab. Triparental conjugation 
was successful in A. japonica, but still no production was seen. To check for transcription of 
the cluster, reverse transcriptase (RT) PCR was performed. RT-PCR primers were designed 
for the NRPS gene, the RS1 gene, the tetR1 gene and the padR gene. sigB was used as a 
positive control. No transcription was seen in the heterologous host. The TetR1 and PadR 
regulators were individually deleted using λ red recombination. RNA was converted to cDNA 
with (+) RT and controls without (-) RT were performed. The designed PCR primers were 
used to amplify from both the + and – RT samples. No transcription was observed for the 
NRPS, tetR1 and padR genes (Figure 8). Transcription of sigB in the + RT samples and not 
the – RT samples confirms that the cDNA conversion was successful. The transcription of 
RS1 was not able to be resolved due to a persistent band in the negative control. PadR 
regulators have been previously shown to be repressors of multi-drug resistance transport 
systems
10,11
. Three multi-drug resistance transporters are directly upstream of and 
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translationally coupled to the NRPS gene, so repression of the transporters could also cause 
repression of the NRPS gene. Therefore, an ErmE promotor was used to replace PadR in an 
attempt to induce expression. RT-PCR of cDNA made from RNA from A. japonica WT, the 
A. japonica + pCAP03/NRPS20 knockout strain and the A. japonica + 
pCAP03/NRPS20ErmEΔPadR replacement strain revealed no transcription of the NRPS 
gene, but transcription of the RS1 and sigB genes (Figure 9).  
Future Directions 
It is unknown why the replacement of a putative repressor with a strong promoter did 
not successfully activate this silent cluster. The RT-PCR primers in the NRPS gene are far 
upstream, so it’s possible that part of this large gene was being transcribed, but not the region 
where the RT-PCR primers were designed. Future experiments could check transcription in 
multiple position of the NRPS gene, the standalone A domain, the oxidoreductase, and in the 
Nocardia sp. CNS044 parent strain. RT-PCR primers were designed for the standalone A 
domain, the oxidoreductase, and the beginning and middle of the NRPS gene. An initial 
attempt at RT-PCR was unsuccessful. All negative controls had a band in them, suggesting 
that the cDNA had been contaminated. All plasmids and heterologous hosts with knockouts 
are stored in replicates and saved at -20°C or -80°C. 
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Figure 8. Transcription of five genes in wild type (WT) and regulator knockouts 
This gel shows amplification of five genes (RS1, TetR1, PadR, NRPS, and SigB) from cDNA 
made from RNA extracted from the A. japonica WT (+) and without (-) RT (lanes one and 
two), A. japonica + pCAP03/NRPS20 + and - RT (lanes three and four), A. japonica + 
pCAP03/NRPS20ΔTetR1 + and - RT (lanes five and six) and A. japonica + 
pCAP03/NRPS20ΔPadR + and - RT (lanes seven and eight). Lane nine is the positive control 
for each gene. Negative controls are shown in the last gel section.  
 
Figure 9. Transcription of X genes in WT and PadRΔErmE replacement 
These gels show amplification with SigB, NRPS, and RS1 primers from cDNA made from 
RNA extracted from A. japonica WT + and - RT (lanes one and two), A. japonica + 
pCAP03/NRPS20 + and - RT (lanes three and four), and A. japonica + 
pCAP03/NRPS20ErmEΔPadR + and – RT (lanes five and six). The last two lanes in each set 
are the positive control and negative control, respectively.  
 
 
SigB           NRPS            RS1 
+   -   +  -    +   -   +    -  +   -   +  -     +   -    +    -  +    -   +   -    +   -   +    - 
NRPS            RS1 
+   -   +  -  +   -  +  -   +     +  -  +   -  + - +  - + -  + 
+   -   +  -  +   -  +  -   +         
+   -   +  -  +   -  +  -   +     +  -  +   -  + - +  - + -  + 
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Chapter 4: Uncultured Cyanobacterial Symbionts of Marine Sponges and 
Their Natural Products 
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4.1  Introduction 
4.1.1 Diversity of Chemistry from Lamellodysidea herbacea Sponges 
 Marine sponges of the family Dysideidae are widely distributed in tropical and 
subtropical waters and have been investigated as a source of diverse natural products for over 
forty years
1
. The Lamellodysidea (formerly Dysidea) genus within the Dysideidae family is 
particularly prolific in the variety of bioactive natural products that have been isolated (Figure 
10). The most well-known class of compounds, due to the environmental toxicity of their 
anthropogenic counterparts, are the polybrominated diphenyl ethers (PBDEs), like 1, first 
isolated in 1972 from Dysidea herbacea, and subsequently from numerous Dysideidae sponges
2-
8
. Astonishingly, PBDEs can make up as much as 12% of the sponge’s dry weight9. 
Polychlorinated molecules are often found in Dysideidae sponges, including amino acid 
derivatives, such as dysidin (2)
10
, dysidenin (3)
11
, the dysideathiazoles
9
, herbaceamide
12
, the 
dysideaprolines
13
, herbamide A
14
, and several diketopiperazines, like 4
15-17
. Numerous distinct 
terpene molecules have been isolated from these sponges, including the sesquiterpenes: 
spirodysin (5) 
18
, herbadysidolide
19
, lamellodysidines
20
, hydroxybutenolide
21
, furodysin (6)
22
 and 
others, including an anti-fouling furano-sesquiterpene
23
. Two other diverse classes of compounds 
have been found in Dysidea herbacea samples: the dysibetaines, three novel betaines, like 7
24
, 
and multiple novel polyoxygenated sterols, like 8
25,26
. A novel UV absorbing mycosporine-like 
amino acid (MAA) pigment (9), commonly found in cyanobacteria, was isolated from an 
Australian Dysidea herbacea
27
. Dysinosins A-D (dysinosin B 10) were also isolated from 
Australian collections of Dysidea herbacea specimens 
28,29
. The dysinosins strongly resemble the 
common cyanobacterial metabolites, the aeruginosides, which have a representative biosynthetic 
pathway already characterized from free-living cyanobacteria
30
.  
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Figure 10. Secondary metabolites previously isolated from Lamellodysidea herbacea.  
Representative examples of secondary metabolites from seven classes isolated from L. herbacea 
specimens. Brominated and chlorinated molecules are seen in the first two classes (1-4). Diverse 
sesquiterpines and other terpenoids are represented in the third class (5-6). Novel betaines, 
polyoxygenated sterols, and mycosporine-like amino acids make up the next three classes with 
one representative shown for each (7-9). Finally, highly modified NRPS compounds similar to 
aeruginosides make up the last class, with dysinosin A (10) shown here. 
 
Such a wealth of chemistry from one family of sponges, with a focus on one species here, 
Lamellodysidea herbacea, is remarkable, but with the abundance of bacteria residing in sponges, 
the true source of these diverse compounds is difficult to decipher. In many cases, sequencing 
the dominant symbiont of an invertebrate assemblage gives indication that the bacterial symbiont 
is a major producer of natural products
31
. For example, in the marine ascidian, Lissoclinum 
patella, the dominant, uncultured cyanobacterial symbiont, Prochloron didemni, was 
demonstrated to be the producer of patellamides A and C through pathway sequencing and 
1 dysidin (2) dysidenin (3) 
4 spirodysin (5) 
furodysin (6) 7 
8 9 dysinosin A (10) 
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heterologous expression
32
. Genomic sequencing of the unculturable symbiont, Entotheonella 
swinhoeii of the sponge Theonella swinhoeii, has exposed the elusive symbiont as the producer 
of almost all polyketides and peptides isolated from these chemically rich sponges
33
. These and 
numerous other studies show that access to genomic information can readily inform the true 
producers of secondary metabolites in symbiotic systems. Recently, we reported the biosynthetic 
gene clusters responsible for PBDEs within the genomes of three sponge cyanobacterial 
symbionts, establishing bacterial biosynthesis of at least one major metabolite isolated from L. 
herbacea sponges
34
. 
4.1.2 Hormoscilla spongelia as an Obligate Symbiont and Natural Product Producer 
 A defining feature of Lamellodysidea sponges is the persistent presence of a filamentous 
cyanobacteria symbiont, Hormoscilla spongeliae (formerly Oscillatoria spongeliae)
35
. These 
symbionts have been shown to consistently inhabit all studied L. herbacea sponges, with distinct 
strains inhabiting morphologically discrete hosts
36,37
. Despite repeated attempts, these symbionts 
have been recalcitrant to culturing efforts and are therefore assumed to be obligate symbionts, 
unable to live outside their host system
38
. Despite their inability to be cultured, the 
cyanobacterial trichomes make up a large portion of the tissue volume of the sponge, up to 40%, 
and are easily isolated by simply squeezing the sponge tissue, which is fortuitous for obtaining 
enriched, albeit unviable, fractions of the cyanobacterial cells
35
. 
 H. spongeliae symbionts have long been suspected to be the natural producers of some 
compounds isolated from L. herbacea sponges. Cell sorting studies showed that the chlorinated 
amino acid derivative 13-demethylisodysidenin was localized to the cyanobacterial cells, while 
the sesquiterpenes spirodysin and dysidenin were found to be co-localized with the sponge 
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cells
39
. A subsequent cell sorting study showed that the presence of a PBDE molecule was 
limited to the cyanobacterial cells and not the sponge cells
40
. A more recent study used the barB1 
sequence from the tri-chloromethyl containing cyanobacterial secondary metabolite, barbamide, 
to amplify a homologue from an L. herbacea sponge. This homologue was used as a 
fluorescently labeled DNA probe, which CARD-FISH analysis showed was hybridizing to 
sequences within the cyanobacterial symbiont
41
. While these localization studies all suggest that 
H. spongeliae is the producer of various halogenated natural products isolated from L. herbacea 
sponges, genomic evidence is the most definitive method to determine the real producers of 
sponge natural products. 
 Here we report the >90% complete population genomes of two H. spongeliae 
populations, isolated from chemically and morphologically distinct L. herbacea sponges, 
collected in Guam. We used a hybrid sequencing and assembly approach with short-read 
Illumina sequencing and long-read PacBio sequencing of enriched cyanobacterial cell fractions. 
Insights from these genomes of uncultured symbionts shed light on their biosynthetic capacity 
for secondary metabolites and give clues to their seemingly obligate symbiont lifestyle. We also 
report the isolation and characterization of fourteen PBDEs (11-24), including penta- and hexa-
brominated molecules not yet reported from Guamanian L. herbacea sponges. A unique 
halogenase in the new hs_bmp cluster may be responsible for the observed extra bromination. 
Additionally, two new putative dysinosins (25-26) were discovered using genome mining and 
LCMS comparison with standards. 
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4.2  Methods 
4.2.1 Sponge Collection and Cyanobacteria Enrichment 
 The sponges used in the study are designated GUM007 and GUM202, with their 
corresponding symbionts named GUM007_hs and GUM202_hs. GUM007 was collected in July 
2015 by snorkel in Pago Bay, located just outside of the University of Guam Marine Lab. 
GUM202 was collected in December 2016 by SCUBA diving in 20-40 feet of water at Anae 
Island in Guam. Both sponges were processed in the same way. Samples were taken back to the 
University of Guam Marine Lab and immediately processed as follows. Fresh sponge tissue was 
sectioned off using a sterile razor blade into sterile petri dishes. Sponge pieces were washed with 
5mL of sterile artificial seawater. 5 mL of sterile artificial seawater or phosphate buffered saline 
were added to the sponge, and the sponge tissue squeezed, resulting in visible exudation of 
cyanobacterial trichomes. This liquid was carefully transferred to a 15 mL conical tube on top of 
5 mL of RNAlater (25 mM Sodium Citrate, 10 mM EDTA, 70 g ammonium sulfate/100 ml 
solution, filtered, pH 5.2). These tubes were spun at 100xg for 5 minutes, yielding a dense dark 
green pellet of cyanobacterial trichomes, which were positively identified by light microscopy 
(Figure 11).  
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Figure 11. Workflow for processing whole sponges and enriched cyanobacteria fractions 
Simplified workflow showing parallel processing and sequencing for whole sponge 
metagenomes using Illumina and enriched cyanobacteria using PacBio, requiring high molecular 
weight (HMW) DNA for long-read sequencing. Two different hybrid assembly methods were 
used to obtain genome assemblies. 
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4.2.2 Enriched Genomic DNA Extraction and Sequencing 
 The enriched cyanobacterial fractions were subjected to genomic DNA isolation using a 
previously published protocol
42
 to obtain high molecular weight DNA enriched for H. spongeliae 
from both GUM007 and GUM202. Isolated DNA was either left dry or resuspended in Tris-
EDTA (TE) and frozen, and shipped back to the Scripps Institution of Oceanography along with 
frozen sponge tissue stored (1) dry, (2) in RNAlater, and (3) in Calcium-Magnesium-Free 
Artificial Seawater with EDTA and glycerol (449 mM NaCl, 33 mM Na2SO4, 9 mM KCl, 2.5 
mM NaHCO3, 1 mM EDTA, 15% w/v glycerol, pH 8.0). Unenriched 147etagenomics DNA was 
extracted from GUM007 and GUM202 whole sponge tissue frozen in RNAlater as previously 
described
34
. Preparation of all libraries and sequencing was performed by the UC San Diego 
Institute for Genomic Medicine. Illumina libraries were constructed from unenriched 
147etagenomics sponge DNA and sequenced as previously described
34
. PacBio libraries were 
constructed from the enriched, high molecular weight DNA isolated in Guam (Figure 11). 
PacBio sequencing libraries were generated using SMRTbell® Template Preparation Reagent 
Kits (Pacific Biosciences) and libraries >6 Kb were selected using a PippinHT® (Sage Science). 
Libraries were sequenced on a PacBio RS II® sequencer (UCSD IGM Genomics Center, La 
Jolla, CA) via four hour movies using the DNA/Polymerase Binding Kit Version P6 V2 with C4 
sequencing chemistry. Whole sponge metagenomes for both GUM007 and GUM202 were 
sequenced following previously published methods
34
. 
4.2.3 Population Genome Assemblies and Quality Assessment 
 The GUM007_hs and GUM202_hs genomes were assembled using two slightly different 
methods (Figure 11). GUM007_hs was assembled first by using quality trimmed Illumina reads 
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that had been classified by DarkHorse version 1.5
43
 and binned, as previously described
34
. The 
PacBio reads were then used to scaffold the Illumina assembled genome using SSPACE-
LongRead
44
 to give the resulting assembly on 64 scaffolds. GUM202_hs was assembled by first 
assembling the GUM202 L. herbacea metagenome using Illumina reads and binning based on 
phylogenetic and coverage information. Illumina reads were then mapped to the H. spongeliae 
bin to give Illumina reads that should belong only to GUM202_hs. The PacBio reads were also 
phylogenetically classified by blasting against a custom made database of protein coding 
sequences from the GUM007_hs genome previously assembled and a database made of protein 
coding sequences for all Oscillatoria genomes in the Joint Genome Institute (JGI) database. Any 
PacBio reads that contained a hit to one of these databases was retained. The raw, binned 
Illumina reads and the raw positive hit PacBio reads were then used for assembly with 
hybridSPAdes
45
. The Illumina reads and the GUM202_hs hybrid assembly were then used as 
input for GapFiller to obtain the final assembly
46
.  
 To determine the quality and completeness of genome assembly, CheckM was used
47
. In 
both cases, genome completeness exceeded 90% according to CheckM parameters. Average 
nucleotide identity (ANI) was calculated by submitting both genome assemblies to the ANI 
Calculator, hosted by the Kostas lab at http://enve-omics.ce.gatech.edu/ani/. Genome synteny 
was examined using Mauve version 20150226 build 10
48
. 
4.2.4 Phylogenetic Analysis 
 To place H. spongeliae in the broader context of sequenced cyanobacteria, we used a 
Multi-Locus Sequence Analysis (MLSA) to build a phylogenetic tree using twenty-five 
conserved housekeeping genes (Table 1) from a set of thirty one genes previously defined for 
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bacterial MLSA
49
. We chose to use twenty-five genes in order to include a wider variety of 
genomes that did not have all thirty one genes. All 442 available cyanobacteria genomes in JGI 
as of January 22, 2018 were searched for the presence of the twenty-five housekeeping genes, of 
which 305 genomes contained each gene in one copy. After eliminating duplicate genomes and 
limiting redundant species to five representatives, a final set of 197 cyanobacteria genomes were 
used in the MLSA (see Supplementary Information). Because the GUM007_hs genome was 
submitted to JGI before their “Metagenome Assembled Genome” category was available, 
GUM007_hs is classified as a metagenome and was searched manually for all housekeeping 
genes using HMMER3
50
, of which it contained all twenty five in single copy. Chloroflexus 
aurantiacus J-10-fl was used as an outgroup to root the tree. Each of the twenty five gene sets 
were individually aligned using MAFFT v7.310
51
 with high accuracy local iterative mode using 
100 iterations. Next, each alignment was trimmed using trimAl v1.2rev59
52
 and the 
“automated1” option optimized for maximum-likelihood tree construction. The resulting 
trimmed, aligned files were concatenated using a custom python script and the resulting 
supermatix was processed with IQ-TREE v1.6.1
53
 with 1000 ultra-bootstrap replicates using 
UF:Boot2
54
 and ModelFinder
55
 for each gene partition. The tree was visualized using interactive 
tree of life (iTOL) v3
56
. Bootstrap values under 95 are displayed in the tree.  
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Table 1. Cyanobacteria housekeeping genes used in MLSA 
Twenty-five genes were chosen to construct a MLSA of cyanobacteria. These genes were chosen 
from a set of thirty one suggested for building bacterial phylogenies. Because many of the 
cyanobacteria in the JGI database do not have all thirty one genes in single copy, the data set was 
narrowed to 25 conserved genes to retain more genomes in the analysis.  
Gene Name Abbreviation pfam or 
TIGRFAM 
Phosphoglycerate kinase pgk pfam00162 
Ribosomal protein L5 rplE pfam00281 
Ribosomal protein L3 rplC pfam00297 
Ribosomal protein L6 rplF pfam00347 
Ribosomal protein S9/S16 rpsI pfam00380 
Ribosomal protein S11 rpsK pfam00411 
Ribosomal protein S13/S18 rpsM pfam00416 
SsrA-binding protein smpB TIGR00086 
translation elongation factor Ts tsf TIGR00116 
ribosome recycling factor frr TIGR00496 
ribosomal protein S2, bacterial type rpsB TIGR01011 
ribosomal protein S5, bacterial/organelle type rpsE TIGR01021 
ribosomal protein L19, bacterial type rplS TIGR01024 
ribosomal protein L20 rplT TIGR01032 
ribosomal protein S10, bacterial/organelle rpsJ TIGR01049 
ribosomal protein S19, bacterial/organelle rpsS TIGR01050 
ribosomal protein L13, bacterial type rplM TIGR01066 
ribosomal protein L14, bacterial/organelle rplN TIGR01067 
ribosomal protein L16, bacterial/organelle rplP TIGR01164 
ribosomal protein L1, bacterial/chloroplast rplA TIGR01169 
ribosomal protein L2, bacterial/organellar rplB TIGR01171 
50S ribosomal protein uL11, bacterial form rplK TIGR01632 
transcription termination factor NusA nusA TIGR01953 
DNA-directed RNA polymerase, beta subunit rpoB TIGR02013 
50S ribosomal protein L4, bacterial/organelle rplD TIGR03953 
 
4.2.5 Primary Metabolism Analysis 
 To determine if any essential genes were missing from the GUM007_hs and GUM202_hs 
genomes, we used the metabolic model developed experimentally for Synecchococcus elongatus 
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PCC 7942, a free-living cyanobacterium, as a comparison
57
. Protein coding regions of both 
GUM_hs genomes were BLASTed against the S. elongatus protein coding regions, resulting in 
155 genes present in S. elongatus, but absent in both GUM genomes. The missing genes were 
converted into their corresponding KO and pfam numbers for analysis in JGI IMG/MER. The 
missing KO numbers were used as a search query in both GUM genomes. KOs that were absent 
in both genomes were cross-referenced against gene essentiality in S. elongatus, as 
experimentally determined using hundreds of thousands of transposon mutants
58
. The same 
process was done using pfams, which often catch genes that may not have been assigned a KO 
function by JGI. The intersection of the two datasets was a set of seven genes missing in the 
GUM_hs genomes and essential in S. elongatus PCC 7942 (Table 2). In order to examine if the 
pathways containing missing genes were actually incomplete, we used ec2kegg
59
 to generate 
metabolic maps for pathway comparison in S. elongatus PCC 7942 and the GUM_hs genomes. 
Moorea producens was also used as a reference genome for a closer phylogenetic comparison in 
ec2kegg. The presence of protein secretion systems was assessed using the hmm models 
developed by Abby et al (2016), utilizing the TXSScan tool in Galaxy
60,61
. Five Roseofilum spp. 
genomes were also downloaded from JGI for comparison in TXSScan and ec2kegg. 
4.2.6 Biosynthetic Gene Cluster Identification and Networking 
 Both genomes were submitted to JGI’s Integrated Microbial Genomes and Microbiomes 
Expert Review (IMG/MER) for detailed annotation. The two genomes were also submitted to 
antiSMASH 4.1.0 with standard options and ClusterBlast selected in extra features
62
. The results 
were examined using the Homologous Gene Clusters output for similarity to publicly available 
sequences and to characterized clusters in the MIBiG database
63
. When similarity to a known 
cluster was detected, all genes in the cluster were submitted to BLAST to determine closest 
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matches and assign putative functions; JGI annotations were also taken into account to assign 
putative functions
64
. NaPDoS
65
 was used to further analyze PKS clusters. Biosynthetic gene 
cluster networking was done using a locally installed version of the BiG-SCAPE software
66
. 
Each cluster Genbank file was extracted from the antiSMASH output and used as input for BiG-
SCAPE with the local option enabled. The resulting pairwise scores were filtered for those above 
0.40 and were visualized as a network using Gephi v0.9.1
67
.  
Table 2. Essential genes from Synechococcus elongatus PCC 7942 missing from 
GUM202_hs and GUM007_hs  
The essential gene analysis using the well curated S. elongatus PCC 7942 metabolic model as a 
reference, resulted in eight genes that are essential for S. elongatus and missing in both 
GUM007_hs and GUM202_hs. Subsequent inspection of each pathway showed that only the 
biosynthetic pathway for histidine was actually incomplete. 
S. elongatus PCC 
7942 Locus tag 
KO / pfam / 
EC 
Name Associated 
pathway (gene) 
Pathway 
Incomplete? 
Synpcc7942_0125 K01693 / 
pfam00475 / 
4.2.1.19 
imidazoleglycerol-
phosphate 
dehydratase   
Histidine 
metabolism (hisB) 
Yes 
Synpcc7942_0475 K03689 / 
pfam03742 
cytochrome b6-f 
complex subunit 8 
Photosynthesis 
(petN) 
No; also 
missing in M. 
producens 
Synpcc7942_0849 K08973 / 
pfam03653 
  
putative membrane 
protein 
Chlorophyll 
Biosynthesis 
(K08973) 
No; HemY 
present 
Synpcc7942_1044 K03465 / 
pfam02511 / 
2.1.1.148 
thymidylate 
synthase (FAD)  
Pyrimidine 
metabolism (thyX, 
thy1) 
No; ThyA 
present 
Synpcc7942_1447 K01673 / 
pfam00484 / 
4.2.1.1 
carbonic anhydrase   Nitrogen 
Metabolism (cynT, 
can) 
No; CcmM 
present 
Synpcc7942_2062 K06443 / 
pfam05834 / 
5.5.1.19 
lycopene beta-
cyclase  
Carotenoid 
Biosynthesis (lcyB, 
crtL1, crtY) 
No; CruA and 
CruP present 
Synpcc7942_2290 K00979 / 
pfam02348 / 
2.7.7.38 
3-deoxy-manno-
octulosonate 
cytidylyltransferase 
(CMP-KDO 
synthetase)   
Lipopolysaccharide 
biosynthesis (kdsB) 
Cannot 
biosynthesize 
Kdo 
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4.2.7 PBDE Structure Elucidation from GUM202 
 Lyophilized GUM202 sponge tissue (1.5 grams) was ground using a mortar and pestle, 
and extracted with methanol (MeOH) 3x 20mL for 30-60 minutes on a benchtop nutator. The 
combined extracts were dried in vacuo and resuspended in dichloromethane (CH2Cl2) and then 
washed with water. The resulting CH2Cl2 layer was dried using magnesium sulfate, filtered, and 
dried in vacuo. Preparative HPLC solvents used were HPLC grade water with 0.1% 
trifluoroacetic acid (TFA) and HPLC grade acetonitrile (MeCN) with 0.1% TFA. Preparative 
HPLC was carried out using an Agilent 218 purification system (ChemStation software, Agilent) 
equipped with a ProStar 410 automatic injector, Agilent ProStar UV-Vis Dual Wavelength 
Detector, a 440-LC fraction collector and an Agilent Pursuit XRs 5 C18 100 x 21.2 mm 
preparative HPLC column (0-5 min 5% MECN isocratic, 5-10 min 10-25% MECN, 10-35 min 
65-75% MECN, 35-40 min 75-100% MECN, 40-45 min 100% MECN isocratic). Thirteen 
fractions were collected and analyzed using LC-MS/MS performed on an Agilent 1260 LC 
system with diode array detector and Phenomenex Kinetex 5μ C18(2) 100 A, 150 x 4.6 mm 
column in negative mode. All LCMS solvents used were LCMS grade water with 0.1% formic 
acid and LCMS grade acetonitrile with 0.1% formic acid. MS were analyzed with Agilent 
MassHunter Qualitative Analysis version B.05.00. Eleven of the thirteen fractions were pure 
enough for NMR. Each fraction was dissolved in deuterated methanol and 
1
H-NMR, COSY, 
HSQC, and HMBC experiments were run on a MACHINE 600NMR. Spectra were analyzed 
with SOFTWARE and were matched to previously reported PBDEs
68
. LCMS and NMR spectra 
used to characterize the eleven PBDEs can be found in the Chapter 4 Appendix. 
4.2.8 Identification of Putative Dysinosin Analogues from GUM007 
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 Due to sample limitations, dysinosin analogues were isolated from GUM007 sponge 
samples stored dry and in RNAlater. Lyophilized GUM007 sponge was ground with a mortar 
and pestle, extracted with 3x 20mL MeOH for 30-60 minutes on a benchtop nutator. The 
combined extracts were dried in vacuo. The MeOH extract and the RNALater solution used to 
store the sponges were loaded onto a C18 solid phase extraction column and fractionated (5% 
MECN, 10% MECN, 15% MECN, 20% MECN, 25% MECN, 30% MECN, 40% MECN, 100% 
MECN). Each fraction was analyzed by LC-MS/MS (see below) and the 15% and 20% MECN 
fractions contained the dysinosin analogues. Four standards, dysinosin A (28), dysinosin B (10), 
dysinosin C (27), and 29, kindly provided by Professor Ron Quinn from Griffith University, 
were prepared as 0.1 mg/ml solutions in MeOH and analyzed in parallel using the Agilent 6530 
Accurate-Mass Q-TOF MS mentioned above with a Phenomenex Kinetex 5μ C18(2) 100 A, 150 
x 4.6 mm column (0-3 min 5% MECN isocratic, 3-23 min 5-100% MECN, 23-26 min 100% 
MECN isocratic at 0.7 mL/min).  Molecular networking, using the Global Natural Products 
Social (GNPS)
69
 molecular networking platform, was used to visualize the relation of the new 
dysinosins and dysinosin standards.  
 
4.3  Results and Discussion 
4.3.1 Enriched Metagenome Assembled Genomes 
 Obtaining high quality draft genomes from uncultured symbionts has proven a unique 
challenge in metagenomics. Often, short-read metagenomics sequencing alone does not produce 
high enough quality complete genomes, especially when examining highly repetitive 
biosynthetic gene clusters, such as non-ribosomal peptide synthetase (NRPS) and polyketide 
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synthase (PKS) containing clusters
70
. For studies of sponge associated obligate symbionts, which 
can have reduced/minimized genomes
71,72
, genome completeness is an imperative measure. 
Recently developed sequencing techniques for high-throughput, long-reads, such as PacBio 
RSII® (Pacific Biosciences) and MinION® (Oxford Nanopore), can be complemented with 
high-accuracy, short-reads obtained from Illumina sequencing
73,74
. Although H. spongeliae has 
never been cultured from any sponge host, we are fortunate that the denser cyanobacteria 
trichomes can be easily squeezed out of sponge tissue and separated from the less dense sponge 
cells by centrifugal partitioning, yielding an enriched fraction containing H. spongeliae cells
38
, as 
assessed by light microscopy.  
 Two sponges, GUM007 and GUM202, yielded large cyanobacterial pellets and also 
exhibited different chemotypes: GUM007 contained no PBDEs, while GUM202 contained an 
abundance of PBDEs. To examine differences in secondary metabolite biosynthetic potential in 
the two sponge symbionts, we undertook a hybrid sequencing and assembly approach. The 
enriched cyanobacterial fractions yielded sufficient quantity and quality of DNA for PacBio 
RSII® sequencing. Additionally, unenriched metagenomes of each whole sponge were 
sequenced in parallel (Figure 11). Hybrid assemblies using binned Illumina reads and 
phylogenetically classified PacBio reads resulted in high quality draft genomes (Table 3). 
GUM007_hs is contained on 64 scaffolds, with an average length of 97 kb, and 91.82% 
completeness, according to CheckM
47
. GUM202_hs is contained on 70 scaffolds, with an 
average length of 98 kb and 93.64% completeness. Additionally, the genomes were checked for 
thirty housekeeping marker genes commonly used in building bacterial phylogenetic trees
49,75
. 
Both genomes had all thirty genes in one copy, further suggesting high quality assemblies. For 
comparison, 210 genomes out of 442 cyanobacterial genomes (47.5%) in JGI had all thirty genes 
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in one copy, suggesting that just under half of the cyanobacterial genomes in JGI pass this low 
bar for genome completeness. The two GUM_hs genomes have an ANI of 96.18%, indicating 
that they belong to the same species, but diverge significantly with regard to synteny. While 
there are regions of the genomes that are syntenic, the two GUM_hs genomes have different 
organization overall, with no two scaffolds being completely syntenic.  
Table 3. Assembly and Quality Statistics for GUM_hs Genomes.   
General assembly statistics for the metagenome assembled genomes for H. spongeliae from 
GUM007 and GUM202 are displayed. CheckM results are also shown, confirming that these 
assemblies are roughly 92-94% complete. A two-way average nucleotide identity (ANI) shows 
that these two genomes are about 96% similar.  
 GUM007__hs GUM202_hs 
# of scaffolds 64 70 
Avg. length of scaffolds (bp) 97,372 98,137 
Longest scaffold (bp) 345,613 304,315 
Est. genome size (Mb) 6.2 6.8 
N50 169,688 161,164 
%GC 47.8% 47.5% 
CheckM total markers 650 650 
CheckM markers detected 477 477 
CheckM completeness (%) 91.82 93.64 
CheckM Contamination 7.56 9.73 
CheckM Strain Heterogeneity 13.70 4.55 
Two-way ANI: 96.18% 
 
 A well supported MLSA phylogenetic tree made using 25 diverse housekeeping genes in 
single copy, extracted from 197 cyanobacteria genomes, shows how these unusual symbionts are 
related to other cyanobacteria (Figure 12). Both H. spongeliae strains clade together and are most 
closely related to multiple Roseofilum strains that are coral pathogens found in corals afflicted 
with Black Band disease
76-78
. Although Roseofilum spp. have been cultured in the lab, they are 
found in microbial assemblage mats that infect corals and have not yet been found free-living in 
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the environment. Comparative genomics of five Roseofilum spp. has shown that they are reliant 
on other members of the microbial consortium, as many filamentous cyanobacteria are, and as H. 
spongeliae appear to be. They are also rich in secondary metabolism biosynthetic gene clusters
76
. 
Other close relatives include Desertifilum spp., which have been isolated from biological desert 
crusts and other microbial mat assemblages
79,80
. 
Figure 12. Multi-Locus Sequence Analysis (MLSA) of Diverse Cyanobacteria.  
197 cyanobacteria genomes containing twenty-five housekeeping genes were used to construct 
this MLSA. H. spongeliae are highlighted in green. Their nearest sister clade are the Roseofilum 
spp., known coral pathogens. Other symbiotic cyanobacteria are highlighted throughout the tree. 
Only bootstrap values between 65-95 are shown, all other bootstrap values are above 95. 
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4.3.2 Genomic Hallmarks of a Symbiont Lifestyle 
 In an effort to understand why Hormoscilla spongeliae has defied laboratory cultivation, 
we compared metabolic pathways and gene essentiality with well characterized free-living 
cyanobacteria. A well curated genome-scale model (GEM) has recently been developed for the 
model cyanobacterium, Synechococcus elongatus PCC 7942
57
. This GEM is informed not just by 
genomic metabolic modeling data, but also by genome wide gene essentiality analysis, 
determined from ~250,000 transposon mutants tested for survival and growth and sequenced 
using random barcode transposon site sequencing (RB-TnSeq) to locate mutation sites and assign 
genes as essential, beneficial, or nonessential
58
. Although the free-living, single celled S. 
elongatus and the symbiotic, filamentous H. spongeliae are different in many ways, and 
differences in gene content are expected, the comparison allows us to leverage the extensive, 
experimentally validated data about gene essentiality in a free-living photosynthetic organism 
and potentially expose missing essential genes in a seemingly obligate symbiont. An initial 
BLAST comparison of the GUM_hs genes against the S. elongatus GEM revealed a combined 
list of 155 missing genes in both GUM_hs genomes. Missing genes were then converted to 
corresponding KO and pfam models for a more robust search. Any models that remained 
unfound were cross-referenced with gene essentiality data for S. elongatus PCC 7942, resulting 
in seven KOs/pfams that are both missing and essential for S. elongatus (Table 2). In order to 
determine if alternative enzymes are used by H. spongeliae in the incomplete metabolic 
pathways, we examined the comparative metabolic maps generated by ec2kegg
59
 using S. 
elongatus PCC 7924 as a reference genome and each GUM_hs as a query genome. Additionally, 
we used the Moorea producens reference genome provided by ec2kegg as a secondary reference, 
as M. producens and H. spongeliae are more closely related and share distinct features including 
a filamentous morphology and large secondary metabolism repertoires
81
.  
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Figure 13. Histidine Metabolism in H. spongeliae vs S. elongatus PCC7942 
Comparison of the biosynthetic pathway for the amino acid, histidine, in S. elongatus, 
GUM007_hs, and GUM202_hs shows an apparent lack of an essential enzyme, 
imidazoleglycerol-phosphate dehydratase (EC 4.2.1.19), which performs the sixth step in 
histidine biosynthesis. 
 Both strains of H. spongeliae are prototrophic for all amino acids except histidine. The 
missing essential gene analysis exposed the lack of imidazoleglycerol-phosphate dehydratase 
(hisB), the enzyme responsible for the sixth step in histidine biosynthesis, in both GUM_hs 
genomes (Figure 13). There does not appear to be an alternative pathway for histidine 
biosynthesis, and both S. elongatus and M. producens harbor hisB. Additionally, a BLAST 
search using the M. producens hisB did not turn up any results in the GUM_hs genomes. Three 
additional assembled genomes for H. spongeliae symbionts of related L. herbacea specimens 
collected in Guam (GUM098, GUM102, and SP12—personal communication, Jessica Blanton) 
also lacked hisB. While it is possible that this gene was not assembled from the sequence data 
generated, it may also indicate that H. spongeliae is a histidine auxotroph, requiring histidine 
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from its host or other members of the microbiome. Alternatively, there could be an unrelated 
gene encoding a novel dehydratase to perform this reaction. 
 A small subunit of the cytochrome b6-f complex, PetN, also appears to be missing in 
both GUM_hs genomes. While PetN was determined to be essential in S. elongatus PCC7942, 
Synechocystis sp. PCC 6803, and Nostoc sp. PCC 7120, it does not appear to be essential for M. 
producens, as this reference genome also lacks PetN
82,83
. The four large subunits of the 
cytochrome b6-f complex, PetA, PetB, PetC, and PetD, are present in both H. spongeliae 
genomes and M. producens. Although their exact function in cyanobacteria remains largely 
unknown, three small subunits of the cytochrome b6-f complex, PetG, PetL, and PetN, have been 
implicated in the assembly and stability of the whole complex in plants
84
. As the cytochrome b6-
f complex plays an essential role in electron transfer between photosystem II and photosystem I, 
it is not likely that this enzyme is dysfunctional in M. producens, but rather that M. producens 
does not require PetN for its cytochrome b6-f complex to function
85
. We therefore conclude that 
this missing gene does not indicate that the cytochrome b6-f complex is missing or dysfunctional 
in H. spongeliae, but that H. spongeliae and the related M. producens may not need PetN for a 
functioning cytochrome b60-f complex, or it may be replaced by a yet unknown protein. 
  We found alternative pathways in H. spongeliae for four other missing essential genes. 
The gene encoding thymidylate synthase, thyx (EC 2.1.1.148), is missing in both GUM_hs 
genomes, but upon further interrogation of the pyrimidine metabolism map (Figure 14), an 
alternative gene, thyA (EC 2.1.1.45), can perform the same transformation and is present in both 
genomes. Upon investigation of the missing essential lycopene beta-cyclase gene, lcyB (EC 
5.5.1.19), we found that M. producens is also missing this gene. M. producens and both H. 
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spongeliae genomes possess two other genes that encode lycopene cyclases, CruA and CruP, that 
can perform the same function of LcyB
86
.  
 
Figure 14. Pyrimidine Metabolism in H. spongeliae vs S. elongatus 
Comparison of the biosynthetic pathways for making pyrimidines in the reference genome, S. 
elongatus and query genomes, GUM007_hs and GUM202_hs, shows that GUM_hs genomes 
have alternative enzymes to complete pyrimidine biosynthesis. 
The missing putative membrane protein (K08973), as annotated in S. elongatus, is 
annotated as protoporphyrinogen oxidase HemJ in M. producens, and has been shown to be an 
enzyme that replaces HemG or HemY in heme biosynthesis
87
. The H. spongeliae genomes 
possess HemY (EC 1.3.3.4) to catalyze the formation of protoporphyrin IX, and thus do not 
require HemJ as S. elongatus and M. producens do (Figure 15). Finally, the missing gene, cynT, 
encodes the enzyme carbonic anhydrase, which acts as a key player in the carbon dioxide 
concentrating mechanism of cyanobacteria. This type of β-carbonic anhydrase resides in the 
carboxysome, where in converts bicarbonate to carbon dioxide for use in photosynthesis
88
. Once 
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genomes of β-cyanobacteria began to be sequenced, it was noticed that they lacked a cytosolic β-
carbonic anhydrase, but contained a CcmM protein with domains homologous to γ-carbonic 
anhydrases
89
. The elucidation of the structure of a cyanobacterial CcmM and subsequent 
experiments confirmed that it acts as a carbonic anhydrase in cyanobacteria lacking a 
conventional β-carbonic anhydrase90. Both H. spongeliae genomes contain CcmM, suggesting 
that it plays the role of the essential β-carbonic anhydrase in S. elongatus. 
 
Figure 15. Porphyrin and Chlorophyll Metabolism in H. spongeliae vs S. elongatus 
The missing putative membrane protein from S. elongatus (K08973) is annotated as HemJ, a 
protoporphyrinogen oxidase, in M. producens. HemJ can replace HemG or HemY, as it does in 
both reference genomes, but both H. spongelie have HemY to complete this step in 
protoporphyrinogen biosynthesis. 
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Figure 16. Lipopolysaccharide Metabolism in H. spongeliae vs. S. elongatus 
The four enzymes in green boxes are responsible for the biosynthesis of ketodeoxyoctonate 
(Kdo), the sugar component of lipopolysaccharides. The pathway is present in S. elongatus and 
M. producens, but absent in H. spongeliae. This pathway is essential for S. elongatus, but it may 
not be essential for H. spongeliae, as it may not use Kdo in its lipopolysaccharide structure. 
The essential missing gene analysis identified the kdsB gene (EC 2.7.7.38) involved in 
lipopolysaccharide biosynthesis, and indeed the entire Kds pathway, as missing in H. spongeliae 
(Figure 16). The Kds pathway, comprised of a suite of four enzymes, KdsA-D, is responsible for 
turning D-ribulose-5P into CMP-3-deoxy-D-manno-octulosonate (ketodeoxyoctonate or Kdo). 
M. producens also has the genes kdsA-C, and the pathway is largely conserved between plants 
and bacteria
91
. While Kdo is often present in the sugar component of lipopolysaccharides in 
Gram-negative bacteria, there have been multiple cyanobacteria found to not contain Kdo
92
. It is 
likely that H. spongeliae has different sugar variants in its lipopolysaccharide structure and 
therefore does not require Kdo. Lipopolysaccharides have been implicated in establishing 
symbiont-host symbioses in a variety of systems
93
. In a legume-endosymbiont association, it was 
found that symbionts with a mutated lipopolysaccharide had defective communication with their 
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plant hosts, which were unable to form nodules
94
. A similar phenomenon was observed in the 
bean bug and its gut symbionts of the genus Burkholderia. In this system, the O-antigen 
component of the Burkholderia lipopolysaccharide is crucial for initial colonization of the bean 
bug, and mutations in the core oligosaccharide resulted in lower colonization rates and decreased 
host fitness
95
. This interesting interaction of symbiont and host through lipopolysaccharides has 
not been explored in H. spongeliae and would be an interesting avenue for further study. 
 
Figure 17. Thiamine Metabolism in H. spongeliae vs S. elongatus 
Both GUM007_hs and GUM202_hs genomes appear to be lacking the three enzymes involved in 
the last step of thiamine biosynthesis (ECs 3.1.3.1, 3.1.3.2, and 3.1.3.100). 
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Of the apparent missing genes in both H. spongeliae genomes that were experimentally 
determined as essential for S. elongatus PCC 7942, the missing imidazoleglycerol-phosphate 
dehydratase appears to be the most problematic for a free-living lifestyle. Additionally, we 
examined the ability of H. spongeliae to produce important co-factors, such as thiamine and 
biotin. In the case of both GUM_hs genomes, the enzymes performing the last step in thiamine 
biosynthesis are missing (EC 3.1.3.1, EC 3.1.3.2, EC 3.1.3.100), but are present in both S. 
elongatus and M. producens (Figure 17). This suggests that H. spongeliae is unable to make 
thiamine, an important co-factor. Likewise, two Entotheonella spp., uncultivated symbionts of 
the marine sponge Theonella swinhoei, also appear to have an incomplete pathway for thiamine 
biosynthesis
96
.  
Also absent in the Entotheonella genomes was the pathway for biotin biosynthesis. While 
H. spongeliae do not completely lack the biotin pathway, they are missing key enzymes present 
in S. elongatus (EC 2.1.1.197, EC 3.1.1.85, EC 2.3.1.47, EC 2.6.1.62), two of which, BioC and 
BioH, are involved in making pimeloyl-CoA, and the remaining two, BioF and BioA, are 
involved in the core steps of biotin biosynthesis from pimeloyl-CoA. However, three of these 
enzymes (BioC, BioH, and BioA) also appear to be missing in M. producens (Figure 18). As 
biotin is a cofactor for acetyl-CoA carboxylase and essential for the production of polyketides 
and fatty acids, it is hard to reconcile M. producens being unable to make biotin. However, three 
enzyme orthologues, BioG, BioK, and BioJ, have all been shown to replace BioH in pimeloyl-
CoA biosynthesis
97,98
, and there appear to be homologues of BioK in M. producens and both H. 
spongeliae. These are annotated as “taurine-2-oxoglutarate transaminase,” with about 32% 
similarity to a published bioK sequence from Jeotgalibacillus marinus DSM 1297. Furthermore, 
low homology is seen between two cyanobacterial bioK sequences (35%) in Prochlorococcus 
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marinus MIT-9211 and Synechococcus sp. CC9902, so even with low similarity, these genes 
could reasonably be biok homologues
97
. While this may provide an alternative to the canonical 
BioH, this does not reconcile the missing core enzymes in the biotin pathway.  
 
Figure 18. Biotin Metabolism in H. spongeliae vs M. producens. 
The biotin pathway appears incomplete in both M. producens and H. spongeliae. Putative 
homologues of BioK, which can replace BioH in pimeloyl-CoA biosynthesis, were found in M. 
producens and H. spongeliae. However, no homologues of BioA (ECs 2.6.1.62 and 2.6.1.105, 
red box) have been found in either species. 
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BioA (Figure 18 red box) is missing in the M. producens genome used as a reference in 
ec2kegg, and all other M. producens genomes searched in JGI. However, bioA, and indeed the 
complete biotin pathway from pimloyl-CoA to biotin, is present in an assembly of a 
heterotrophic bacteria living with M. producens from Palmyra Atoll (JGI Genome ID: 
2630968267)
99
. Interestingly, M. producens, and other filamentous cyanobacteria, are unable to 
be cultured axenically, and always grow with heterotrophic bacteria (personal communication, 
William Gerwick). Thus, it is possible that neither M. producens nor H. spongeliae can make 
biotin on their own and rely on heterotrophic bacteria for provision of this important co-factor.  
 While it is hard to pin-point missing essential genes from unfinished genomes that would 
lead to a specific reason why a symbiont may be uncultivable, our analysis provided a few 
possibilities. Future cultivation efforts should include addition of histidine, thiamine, and biotin 
to address possible deficits in these biosynthetic pathways. When comparing the H. spongeliae 
and L. herbacea symbiosis to other well studied bacterial symbioses, like those seen in plants 
and insects, many of the canonical symbiotic traits are absent. Often obligate symbionts undergo 
extreme genome reduction, such as that seen in Ca. Synechococcus spongarium, a cyanobacterial 
symbiont of diverse sponges
71
. However, H. spongeliae does not appear to have a minimized 
genome, with estimated genome sizes between 6.2 – 6.8 Mb, comparable to other free-living 
filamentous cyanobacteria. The same trend was seen in the uncultivatable Prochlorococcus 
didemni symbionts of tunicates
100
. Also observed in P. didemni was a normal GC content for 
cyanobacteria (41-42%), which we see in H. spongeliae as well (46-47%), while obligate 
symbionts usually have a higher AT content than their free-living counterparts
101
. In addition to 
reduced genome size and higher AT content, a lack of mobile elements is seen in long-standing 
symbioses
102
. However, in recently established symbiotic systems, an abundance of such mobile 
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elements is common and H. spongeliae does indeed have an abundance of mobile genetic 
elements: GUM007_hs has 226 genes annotated as a transposase and GUM202_hs has 318. 
Genome minimization is postulated to take place in two separate stages, the first of which retains 
transposable elements. It is possible then, that the H. spongeliae – L. herbacea symbiosis is a 
recently established one and H. spongeliae has yet to undergo extreme genome reduction.  
It has also been suggested that symbionts may have begun their symbiosis with a host as 
a pathogen, due to the shared molecular mechanisms between pathogens and symbionts
103
. These 
genomic hallmarks are especially seen in secondary symbionts, which are recently acquired and 
facultative from the host’s perspective. Examples of shared molecular mechanisms between 
pathogens and symbionts include protein secretion systems, such as the type III secretion system 
(T3SS), dynamic processes, such as an abundance of transposons and bacteriophage sequences, 
and the presence of toxins
103
. While the H. spongeliae genomes do not contain a complete T3SS, 
they do contain a complete type I secretion system (T1SS), and retain genetic hallmarks from 
other secretion systems. Additionally, H. spongeliae genomes carry an abundance of mobile 
genetic elements and the capacity to make toxins. Furthermore, H. spongeliae’s closest 
sequenced relatives belong to the Roseofilum genus, known coral pathogens. It is therefore 
possible that H. spongeliae and Roseofilum spp. share a pathogenic lifestyle, with H. spongeliae 
recently establishing a symbiosis with L. herbacea. 
4.3.3 Secondary Metabolite Biosynthetic Gene Clusters 
 The completeness of the two genomes afforded us a comprehensive look at the 
identifiable biosynthetic gene clusters within these uncultured H. spongeliae specimens. 
AntiSMASH 4.1.0 without ClusterBlast results for both GUM007_hs and GUM202_hs are 
shown in Figure 19a. A total of fifteen clusters (after splitting an unlikely NRPS/bacteriocin 
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hybrid cluster) were found in GUM007_hs and eighteen in GUM202_hs. A gene cluster 
similarity network of all antiSMASH identified gene clusters reveals that the genomes share six 
clusters, roughly one third of their biosynthetic gene clusters, making two thirds of the gene 
clusters unique to each organism (Figure 19b). Of those shared, two are terpene clusters likely 
encoding carotenoid pigments, two are bacteriocins / ribosomally synthesized and post-
translationally modified peptides (RiPPs), one is a T1PKS common in other filamentous 
cyanobacteria, and one NRPS cluster (Figure 19c). The shared NRPS cluster has all the 
hallmarks of being a mycosporine-like amino acid (MAA) with possibly a novel structure. 
MAAs are known to be common metabolites of cyanobacteria, algae, fungi, and lichen, 
with UV protective properties, and may also contribute to environment amelioration as 
compatible osmolytes and antioxidants
104
. The biosynthetic pathway for shinorine, one such 
MAA, has been elucidated, and it was found that a core set of four genes are necessary to make 
shinorine: an NRPS-like gene, an ATP grasp gene, an O-methyltransferase gene, and a DHQS-
like gene
105
. The adenylation (A) domain of the NRPS-like protein in the shinorine pathway is 
predicted to activate a serine, and this was observed to be incorporated into the shinorine 
structure by radio-labeled feeding experiments
105
. As MAAs are a common UV protecting 
metabolite in cyanobacteria, it is not surprising that we found almost identical putative MAA 
gene clusters in both GUM007_hs and GUM202_hs. In the case of both putative MAA gene 
clusters, all four essential genes determined from the characterized shinorine cluster
105
 are 
present, suggesting the necessary machinery to make a MAA compound is existent. The A 
domain in the NRPS gene in both GUM007_hs and GUM202_hs clusters is predicted to have a 
specificity for proline, as determined by consensus of all A domain predictor software used by 
antiSMASH 4.1.0. Additionally, the putative MAA cluster in GUM202 may contain a second 
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NRPS gene, with an A domain selective for serine. To our knowledge, no cyanobacterial MAA 
compound incorporating proline has been described
106
. However, the structure of mycosporine-2, 
discovered in fungi, does contain a proline moiety
107
. We did not attempt to isolate an MAA 
molecule from our extracts, but the characteristic UV trace was seen in HPLC chromatograms 
for both samples (data not shown). 
The remaining NRPS gene clusters in GUM007_hs and GUM202_hs are unique to their 
respective genomes. Additionally, all but one NRPS cluster (excluding those encoding putative 
MAAs) have no significant homology to known clusters in MIBiG, or to other sequenced 
organisms, as determined by MultiGeneBlast run in antiSMASH. The one NRPS cluster with 
homology to a characterized pathway is highly similar to the characterized aeruginoside 
cluster
108
. Dysinosins A-D have been isolated from L. herbacea sponges collected in Australia 
and are structurally related to the aeruginosides isolated from numerous cyanobacteria. We 
provide evidence for this putative dysinosin cluster and further discussion in 4.3.6.  
The shared T1PKS cluster consists of one (GUM007_hs) or two (GUM202_hs) PKS 
genes with four total domains: KS, AT, KR, and DH. The KS domain is determined to be an 
enediyne KS, and the gene cluster seems to be partially conserved in multiple filamentous 
cyanobacteria (Figure 20a). Enedyine natural products are rare, with few characterized examples, 
most of which are isolated from actinomycetes, with two isolated from marine ascidians
109
.  
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Figure 19. Secondary Metabolite Biosynthetic Gene Clusters of two Hormoscilla spongeliae 
Figure 19a is a Circos diagram showing the number and classes of biosynthetic gene clusters in 
the GUM007_hs genomes. Figure 19b is a gene cluster similarity network made with BiG-
SCAPE. Each node represents a gene cluster and those with similarity over a 0.4 threshold are 
connected by a line. The weight of the line indicates higher similarity for bolder lines. Figure 19c 
is the same network with each node colored according to antiSMASH classification.
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The only enedyine natural product isolated from cyanobacteria is fischerellin A, from 
Fischerella muscicola
110
. Fischerellin A contains an uncyclized enedyine moiety, while most 
other characterized enediyne containing molecules belong to nine or ten membered ring 
systems
109
. The KS domains from the GUM_hs genomes were analyzed using NaPDoS
65
 and 
form a sister clade with enediyne KS domains, but do not clade directly with them (Figure 20b). 
The enediyne KS domains and the GUM_hs KS domains are all sister clades to KS domains 
involved in poly-unsaturated fatty acid (PUFA) biosynthesis. As the GUM_hs KS domains 
appear phylogenetically distinct from characterized enediyne KS domains, it is possible that they 
are involved in novel enediyne PKS biosynthesis, and perhaps the formation of non-cyclized 
enedyine molecules like fischerellin A. 
 The GUM_hs genomes both contain two terpene clusters, which share similarity and 
likely are involved in making carotenoid-like pigments. Both clusters contain a phytoene 
synthase and accompanying tailoring enzymes, including terpene cyclases and dehydrogenases. 
These terpene clusters do not appear to be responsible for the diverse sesquiterpene molecules 
isolated from L. herbacea sponges, which have long been postulated to be produced by the 
sponge host. Finally, the two shared RiPP clusters have no predicted products based on 
bioinformatic analysis. One of the shared RiPP clusters has similar elements to the gene clusters 
responsible for making the many and varied cyclic cyanobactins
111
, including both a YcaO 
protein and a SagB-like dehydrogenase. The remaining gene organization, however, does not 
highly resemble canonical cyanobactin pathways, and both pathways are closely flanked by a 
PyrG superfamily CTP synthase homologue, likely involved in primary metabolism. 
Cyanobactin-like molecules have never been isolated from L. herbacea sponges and these RiPP 
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clusters may represent active cyanobactin-like gene clusters, or perhaps cyanobactin-like gene 
clusters in the process of deactivation. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Shared Enediyne Type 1 PKS 
In Figure 20a, the MultiGeneBlast output (as run in antiSMASH 4.1.0) shows a shared T1PKS 
biosynthetic gene cluster among multiple strains of cyanobacteria. The NaPDoS analysis in 
Figure 20b shows that the GUM_hs KS domains form a sister clade with characterized enediyne 
KS domains. Both these clades form a sister clade with PUFA KS domains. 
GUM007 Hormoscilla spongeliae 
GUM202 Hormoscilla spongeliae 
GUM202 KS GUM007 KS 
a 
b 
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Overall, the biosynthetic gene clusters in the GUM_hs genomes are of varying classes, 
with a few bioinformatically predicted structures: structurally varied PBDEs, aeruginosin-like 
dysinosins, MAAs, and carotenoid-like pigments. These predicted structures correspond with 
molecules isolated from L. herbacea sponges that have been historically attributed to H. 
spongeliae. This new genetic evidence provides sound reasoning for attributing these compounds 
to the symbiont, H. spongeliae.  
4.3.4 Genetic Expansion in hs_bmp Cluster Leads to Structural Variety of PBDEs 
 Previous investigations of three clades of H. spongeliae (Clades Ia, Ib, and IV), which are 
prolific producers of PBDEs, have revealed that PBDE biosynthesis is encoded on the semi-
variable hs_bmp gene cluster
34
. At the very minimum, three core enzymes are needed to 
assemble PBDEs: Bmp5, a flavin-dependent brominase, Bmp6, a chorismate lyase, and Bmp7, a 
cytochrome P450 that couples the two brominated phenolic rings
112
. Using these fundamental 
biosynthetic features, we queried the genomes of GUM202_hs and GUM007_hs.  While the 
hs_bmp gene cluster is absent from GUM007_hs, in accordance with its secondary metabolite 
profile, GUM202_hs possess an expanded bmp gene cluster. Previously, we observed a variable 
genomic region between hs_bmp6 and hs_bmp7 in the three sequenced hs_bmp clusters, one of 
which contains hs_Bmp12, a cytochrome P450 hydroxylase that was shown to be responsible for 
doubly hydroxylated PBDEs exclusive to Clade Ia (Figure 21). The variable region in the 
GUM202 hs_bmp pathway also contains a homologous gene for the extra P450 hydroxylase, 
hs_Bmp12 from the Clade Ia H. spongelia (Figure 21) as well as a gene encoding a second 
putative flavin-dependent halogenase, hs_Bmp18, with 78% pairwise nucleotide identity to the 
GUM202 hs_Bmp5. 
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Based on the genomic analysis of the hs_bmp cluster in GUM202_hs, we predicted that 
PBDEs isolated from this sponge would have higher degrees of halogenation, due to the extra 
putative halogenase, and could be doubly hydroxylated due to the extra cytochrome p450 
hydroxylase. Consistent with this genotype, the major PBDEs isolated from GUM202 show a 
higher degree of bromination from previously isolated PBDEs in Guamanian L. herbacea 
specimens, and are doubly hydroxylated, matching the biosynthetic capacity seen in the 
GUM202 hs_bmp pathway. Notably, penta- and hexabromination had not been seen in our Guam 
sponge collections previously.  
 
Figure 21. Hs_bmp clusters in four Hormoscilla spongeliae genomes 
Four hs_bmp clusters from H. spongeliae genomes from four morphologically distinct 
Dysideidae sponges. The variable region of the gene cluster contains extra genes that correspond 
to the chemistry produced by each strain. The additional p450 hydroxylase is responsible for the 
extra hydroxylation in the molecules isolated from the clade Ia sponge (20), and the GUM202_hs 
p450 hydroxylase is 99% identical, corresponding with the double hydroxylation observed (22, 
23). The GUM202_hs cluster contains an extra putative halogenase that is possibly responsible 
for the extra bromination seen in the PBDEs isolated from this sample. 
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Figure 22. Wide variety of poly-brominated diphenyl ethers (PBDEs) isolated from 
GUM202 
The eleven PBDEs isolated from GUM202 are all doubly hydroxylated, consistent with the 
presence of a p450 hydroxylase in the GUM202 hs_bmp cluster. A second putative halogenase is 
also encoded in the cluster and is likely responsible for the high degree of bromination observed. 
Additionally, the tetra-, penta-, and hexabrominated scaffolds all have O-methylated structures 
(20-23). 
Eleven PBDEs were isolated from GUM202 (Figure 22) and structurally characterized by 
tandem mass spectrometry and 1D and 2D NMR spectroscopy in accordance to previously 
reported NMR chemical shift trends (Chapter 4 Appendix)
68
. Typically, extracts from GUM202 
were dominated by a hexabrominated, doubly hydroxylated PBDE (19), which is consistent with 
the additional halogenation potential within the variable region of the hs_bmp cluster. Among the 
remaining PBDEs isolated, all are twice hydroxylated, (one hydroxyl group on each ring) with 
varying amounts of bromine substitution ranging from three (13) to six (19, 23). For the tetra-, 
13            14       15 
16          17      18
 
 11            12     13 
19         20     21 
22            23 
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penta-, and hexa-brominated molecules, the corresponding O-methylated products were also 
identified (20-23).  
4.3.5 Potential for Halogenated Pathways in GUM007_hs 
 
Figure 23. Genomic context of hs_bmp cluster in GUM202_hs and syntenic region in 
GUM007_hs 
The genomic region upstream of the hs_bmp cluster in GUM202 corresponds to a syntenic 
region in GUM007_hs. This region contains ABC transport and secretion genes. In GUM007_hs, 
the syntenic region is flanked by two CRISPR arrays where the hs_bmp cluster “should be” and 
two transposases where synteny ends. 
 With GUM007 lacking the hs_bmp pathway and therefore PBDEs, we wanted to examine 
what the corresponding region of the genome looks like in GUM007_hs (Figure 23). The region 
directly preceding the hs_bmp cluster in GUM202 has a roughly 8 kb region of synteny with 
GUM007_hs. In the area where the hs_bmp pathway “should be” in GUM007, there are two 
series of CRISPR arrays, suggesting a mobile region of the genome where the hs_bmp cluster 
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can move in or out of the genome. On the other side of the syntenic region, two transposases 
mark the end of synteny between GUM007_hs and GUM202_hs.  
PBDEs are not the only halogenated natural products from L. herbacea sponges; a variety 
of polychlorinated amino acid-derived compounds have also been reported. Over the last four 
decades, multiple groups have reported that when PBDEs are found, polychlorinated amino acid 
derivatives are not found, and vice versa
37
. However, in the isolation of dysidenin (3), a 
hexachlorinated amino acid-derived metabolite from an Australian Dysidea herbacea, the 
authors describe two major fractions, the first one being a PBDE, and the second being 
dysidenin
11
. To our knowledge, this is the only reported case where both PBDEs and 
polychlorinated amino acid-derived compounds are present together. It is possible that the 
specimen was a mixed population of sponges, but without further evidence, this cannot be 
known. Regardless, co-occurrence of the two types of metabolites may be a rare case, as this 
hasn’t been seen since the 1977 isolation of dysinenin.  
We did not observe any polychlorinated molecules in the extracts of GUM007, which 
lacks PBDEs, but we queried the genome for halogenases nevertheless. We searched the 
GUM007_hs genome using the dysB1 putative halogenase gene, amplified previously from a H. 
spongeliae containing L. herbacea sponge that makes a leucine-derived hexachlorinated 
molecule, (-)-neodysidinin, as a query
41
. Two matches were found using a tblastn search against 
the GUM007_hs genome, however, they have low homology to dysB1, with 28.3% and 23.2% 
pairwise identity. The similarity between dysB1 and barB1, from a free-living cyanobacteria that 
makes the chlorinated leucine-derived barbamide, was 93%, suggesting that the halogenases 
found by BLAST in GUM007_hs are not of the same class that halogenates leucine in barbamide 
and similar molecules. They do, however, appear to be in the genomic context of possible 
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secondary metabolite gene clusters, as both are identified within putative gene clusters when 
antiSMASH4 is run with clusterblast enabled (Table 4). A third putative halogenase is annotated 
by JGI as a tryptophan halogenase, and also appears to be in the context of a putative 
biosynthetic gene cluster, although ClusterFinder did not designate the genomic region around it 
as a putative gene cluster (Table 4). However, BLAST analysis of the surrounding genes, reveals 
ORFs with high homology to a phenylacetate-CoA ligase, a methyltransferase, a thioredoxin, 
and a multi-drug resistance efflux transporter, all suggestive of a secondary metabolite gene 
cluster. GUM007 is a unique L. herbacea sponge, in that no halogenated products are seen from 
this collection, and we confirmed that the hs_bmp cluster is not present in the GUM007_hs 
genome. There are, however, three putative halogenases that do not have high homology to the 
dysB1 gene, but may be involved in the production of other halogenated secondary metabolites. 
Table 4. Halogenase genes from GUM007 
Three putative halogenases were found in the GUM007 genome. They all reside in operons that 
have hallmarks of secondary metabolite biosynthetic gene clusters. ClusterFinder (CF) identified 
two of these putative secondary metabolite clusters. 
JGI Gene ID JGI Annotation BLAST hit 
[organism] 
(cov%/id%) 
CF Genomic Context 
Ga0115830_10222 Ectoine 
hydroxylase-
related 
dioxygenase, 
(PhyH) family 
phytanoyl-CoA 
dioxygenase family 
protein 
[Planktothrix 
tepida] (85%/52%) 
Yes Methyltransferase 
(MT), dioxygenase 
(DO), epimerase (E), 
transaminase (TA) 
Ga0115830_102250 non-haem Fe2+, 
alpha-
ketoglutarate-
dependent 
halogenase 
halogenase [Nostoc 
sp. 'Peltigera 
membranacea 
cyanobiont'] 
(98%/52%) 
Yes Phenylproionate DO, 
acetyltransferase (AT), 
E, MT, decarboxylase 
Ga0115830_11198 Tryptophan 
halogenase 
tryptophan 7-
halogenase [Nostoc 
sp. PCC 7524] 
(95%/53%) 
No Phenylacetate CoA 
ligase, 
deoxyribosyltransferase, 
MT, multidrug 
resistance protein 
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4.3.6 Genome Mining Leads to Novel Dysinosins 
The advent of bacterial whole genome sequencing uncovered a wealth of cryptic 
biosynthetic gene clusters which spurred the development of the field of genome mining. 
Additionally, advances in synthetic biology have allowed researchers to interrogate and 
characterize numerous biosynthetic gene clusters encoding natural products. Curation of known 
gene clusters aids in the identification of related compounds through gene cluster similarity 
comparisons. Genome mining identified a putative dysinosin pathway in the H. spongeliae strain 
from GUM007. The dysinosins have been reported from L. herbacea sponges previously and 
share the majority of their structure with aeruginosides
28,29
. Dysinosins are potent inhibitors of 
the blood coagulation cascade factor VIIa and the serine protease thrombin
28
. Activity assays 
showed that the desulfated dysinosin D has ten times less activity against both targets, while the 
glycosylation seen in dysinosin B increased activity against factor VIIa and had a slight loss in 
selectivity for thrombin
29
. Structural studies showed that the hydroxyl group on the 2-carboxy-6-
hydroxyoctahydroindole (Choi) moiety lies within the P2 pocket of thrombin and modification of 
this region could have the potential for improved activity and selectivity. Understanding the 
biosynthetic basis of these bioactive molecules would provide a platform for rational molecule 
design for more effective and selective inhibitors in the blood coagulation cascade.  
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Figure 24. Gene cluster comparison and molecular network of dysinosins  
Figure 24a shows the gene cluster found in GUM007_hs compared with the gene cluster for 
aeruginoside 126A (26). In GUM007_hs aerA is missing and aerB is expanded and contains a 
sulfotransferase domain. GUM007_hs also contains an extra gene shown in a pink box that is 
annotated as an isomerase. The molecular network includes dysinosins B (27) and C (28), and 
the two new dysinosins (25, 26) in GUM007. Parent masses and the neutral mass loss of sulfate 
for each structure are displayed inside each node.  Nodes are colored according to their source 
sample. 
An NRPS cluster in GUM007_hs has very high homology to the aeruginoside cluster 
deposited in MIBiG (BGC0000297) (Figure 24a). The GUM007_hs NRPS cluster contains 
homologous genes to aerB, an NRPS gene with an A domain selective for leucine, aerC-F, genes 
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responsible for assembling the unique Choi moiety, aerG, another NRPS gene, predicted to 
activate and incorporate the Choi moiety, and aerI, a putative glycosyltransferase
108
. The only 
notable gene missing is aerA, the NRPS loading domain, which activates phenylpyruvate. When 
comparing the structures of aeruginoside and the related dysinosins, isolated from Australian L. 
herbacea specimens, the major difference is in the starting units: in aeruginoside, the unusual 
phenyllactic acid and in the dysinosins, a sulfated glyceric acid. The aerB homologue in 
GUM007_hs, is likely responsible for loading the sulfated glyceric acid, as a sulfotransferase 
domain is present. Additionally, adenomethyltransferase and Fkbh domains are present in aerB, 
which can also be implicated in constructing the unusual sulfated glyceric acid moiety. AerB 
contains two peptidyl carrier protein (PCP) domains, one condensation (C) domain, an A domain 
with no consensus specificity predicted by bioinformatic tools, and an epimerization (E) domain. 
Taken all together, AerB, a large multimodular NRPS-type complex, appears to be responsible 
for the activation of a sulfated glyceric acid and addition of an unspecified D-amino acid. The 
remainder of the biosynthetic gene clusters, and their corresponding molecules, are nearly 
identical. We therefore believe that this represents a putative biosynthetic gene cluster for a 
dysinosin-like molecule. Isolation attempts are underway, and comparison of GUM007 extracts 
with dysinosin standards led us to two masses for two putative novel dysinosins 25 and 26 
(Figure 6b). 
 The logical bioinformatic basis for a putative dysinosin cluster led us to examine 
GUM007 extracts for dysinosin-like molecules. To aid in our LC-MS/MS-based molecular 
search, we obtained two dysinosin standards from the Quinn Lab at Griffith University for 
comparison. We discovered masses representing two new dysinosins (25, 26). These molecules 
are identical to dysinosins B (27) and C (28) except they have one hydroxylation on the Choi 
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moiety instead of two. Further interrogation of MS/MS data revealed that in each of the 
standards, a neutral mass loss can be observed, in source and via collision induced dissociation, 
which is consistent with the loss of sulfate (79.95) from the terminal glyceric acid residue. We 
also observed this neutral loss of 79.95 in the new GUM007 dysinosins. GNPS
69
 molecular 
networking produced a network of parent masses and corresponding neutral mass loss for both 
standards and the two new dysinosins (Figure 6b). The molecular network shows that all three 
samples contain m/z 619.274 and m/z 539.385, corresponding to dysinosin C with and without 
sulfate and dysinosin B without glucose, with and without sulfate, as is expected. The presence 
of these masses is not consistent across multiple GUM007 extracts. It is possible that there was 
some contamination of the extract, carryover in the MS column, or minute amounts of these 
known dysinosins may have only been picked up in this sample. The new dysinosins were found 
to have masses of 603.2806 (0.17 ppm error from theoretical m/z 603.2807) and 765.3327 (1.04 
ppm error from theoretical m/z 765.3335).  
Further examination of the MS
2
 spectrum of these masses gave fragmentation patterns 
consistent with (25) (Figure 25) and (26) (Figure 26). As noted previously, the in source and 
collision induced loss of sulfate can be seen in MS
1
 and MS
2
 for both dysinosins, and is the most 
abundant species in both cases. Most fragmentation on this molecule occurs in the guanidyl 
group. The next major fragment in 25 represents the de-sulfated core structure with a loss of the 
two terminal amino groups on the guanadyl moiety (m/z 481.2934). The next major fragments 
observed are the Choi and guanadyl core with successive loss of terminal amino groups (m/z 
322.2230, 305.1908, 280.2031). This successive loss is seen again in just the guanadyl fragment 
(m/z 155.1001, 140.1049, 113.1090). The ‘a ion’ produced when the valine is fragmented from 
the Choi can also be seen (m/z 174.1119), as can the ‘b ion’ (m/z 202.1006). Finally, the valine 
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immonium ion is seen (m/z 72.0831). Similar fragmentation is seen in the MS
2
 for 26. Again, the 
main ion is the loss of sulfate (m/z 685.3779), followed by a loss of glucose (m/z 523.3259). The 
glycosylated fragment with a loss of sulfate and loss of both termainl amino groups from the 
guanadyl moiety can be seen (m/z 643.3323). The glycosylated Choi and guanadyl core is seen 
(m/z 484.2889) as well as the loss of both terminal amino groups (m/z 442.2736). The remaining 
fragments labelled with an asterisk match those seen in 25 (Figure 25). Although we have not yet 
isolated enough of the new dysinosins for full structural elucidation via NMR, we are confident 
that the MS/MS data, molecular networking, and genomic information support the discovery of 
two new dysinosins. This discovery represents the first example of genome mining in a 
metagenome assembled genome of an uncultivated symbiont resulting in new structures. 
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Figure 25. MS/MS spectra of new dysinosin (25) 
The upper panel shows the MS1 of 25. The lower panel shows the MS2 for the 603.2806 parent 
mass, with structures of observed fragment ions. The desulfated mass was always observed as 
both a neutral mass loss in source and via collision induced dissociation.
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Figure 26. MS/MS spectra of new glycosylated dysinosin (26)  
The upper panel shows the MS
1
 of 26. The lower panel shows the MS
2
 for the 765.3327 parent 
mass, which is the glycosylated verson of 25. Observed ions are drawn with arrows to their 
corresponding m/z. Multiple fragment ions also seen in Figure 25 are marked with an asterisk 
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4.4  Conclusions 
 Symbiotic associations between microbes and their eukaryotic hosts provide fascinating 
systems to study interdependence and the use of chemical entities in these holobiont systems. L. 
herbacea sponges have a long history of natural product discovery and an even longer 
association with their symbiotic cyanobacteria, H. spongeliae. H. spongeliae have long been 
implicated as a source for many of the varied natural products isolated from L. herbacea. The 
high quality draft genomes generated for two H. spongeliae populations afforded a complete 
look at the biosynthetic capacity of these uncultivatable symbionts. The genetic evidence 
presented here is the strongest yet for cyanobacterial production of multiple classes of 
compounds isolated from these sponges. Furthermore, we found the largest expansion yet of the 
hs_bmp gene cluster in the GUM202_hs genome, which corresponds with the most varied set of 
PBDEs isolated from the Guamanian L. herbacea GUM202. Genome mining and identification 
of a putative dysinosin pathway informed the search for dysinosins in the GUM007 extracts. 
Indeed, this genomic information spurred chemical search lead to two new dysinosins. 
Comparison of H. spongeliae genomes with well characterized free-living cyanobacteria exposed 
multiple avenues for exploring these symbionts’ recalcitrance to cultivation in the lab. We 
determined that an incomplete histidine pathway may be the likely culprit, along with incomplete 
thiamine and biotin pathways, both necessary cofactors. Additionally, H. spongeliae’s relation 
and shared genomic features with known coral pathogens suggests a shared pathogenic lifestyle, 
which for H. spongeliae morphed into a symbiosis with sponges. Overall, the metagenome 
assembled genomes for these captivating symbionts revealed a wealth of information into their 
lifestyle and capacity to produce bioactive natural products. Further efforts to cultivate these 
cyanobacteria can now be informed by genomic information and numerous orphan gene clusters 
are awaiting exploration. 
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4.6  Chapter 4 Appendix 
 
The following spectra were used to characterize the eleven PBDEs isolated from 
GUM202. Not all distinct peaks yielded enough pure compound to perform NMR, so efforts 
were focused on isolating PBDEs exclusively seen in GUM202 and not in previously collected 
Dysideidae sponges from Guam. Compounds 14 - 15 were characterized based on LCMS m/z, 
fragmentation, and characteristic bromination patterns. Compounds 13 and 16 - 23 were purified 
in enough quantity to characterize via NMR. Four experiments were run in deuterated methanol 
for each compound: 
1
H-NMR, COSY, HSQC, and HMBC.
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NMR spectra of compound 13; 1H-NMR, COSY, HSQC, HMBC 
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Hi-Res LC/MS of compound 14 
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Hi-Res LC/MS of compound 15 
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 NMR spectra of compound 16; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 17; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 18; 1H-NMR, COSY, HSQC, HMBC  
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NMR spectra of compound 19; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 20; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 21; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 22; 1H-NMR, COSY, HSQC, HMBC 
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NMR spectra of compound 23; 1H-NMR, COSY, HSQC, HMBC 
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